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ABSTRACT 
 Cytochromes P450 catalyze monooxygenations of relatively inert substrates.  The 
significance of this activity in physiology and industry has inspired many to capture this 
activity in vitro.  However, practical applications of P450s will continue to be hindered 
by the need for reducing equivalents from NAD(P)H.  While electrochemical methods 
provide a potential solution, the difficulty in achieving good electronic coupling to the 
heme remains an enormous obstacle. 
 Flavocytochrome P450 BM3 is soluble, well-characterized, and easily 
manipulated, making it a good target for in vitro applications.  Bioelectrocatalysis was 
first attempted with holo BM3 using a novel electrochemical mediator, 1,1’-
dicarboxycobaltocene (Mred).  Absorption spectroscopy confirmed electron transfer (ET) 
from Mred to the cofactors, while electrolyses resulted in Mred-mediated hydroxylation of 
lauric acid by both the holo (16.5 nmol product / nmol enzyme / min) and heme proteins 
(hBM3) (1.8 nmol product / nmol enzyme / min).   
Subsequent bioelectrocatalysis was attempted with the more stable hBM3.  We 
achieved direct electrochemistry of hBM3 by wiring it through engineered surface Cys387 
to a basal plane graphite electrode (BPG) with 1-pyreneiodoacetamide (Py).  AFM 
images revealed that only pyrene-wired enzyme molecules adsorb to BPG.  ko for the 
BPG-Py-hBM3 system was 650 ± 50 s-1.  Rotated-disk electrode (RDE) experiments 
show that the BPG-Py-hBM3 system catalyzes the four-electron reduction of dioxygen to 
water.  Analogous experiments were performed with enzyme labeled at Cys62, which is 
spatially adjacent to Cys387 but does not provide a similar well-coupled through-bond 
pathway to the heme.  Surprisingly, the Cys62 mutant showed similar electrode kinetics, 
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demonstrating that the pyrene tether does not provide a unique pathway, but probably 
anchors the protein onto the electrode surface in a favorable docking mode for ET. 
Extensive electrochemical characterization of hBM3 was conducted in various 
surfactant films on BPG.  Cyclic voltammetry of hBM3 in SDS films revealed the FeIII/II 
redox couple at -330 mV (vs. Ag/AgCl, pH 7.4), and ko of 40 s-1.  Although voltammetry 
confirmed catalytic dioxygen reduction by FeII, substrate oxidation was not observed.   
Voltammetry of hBM3 mutant 1-12G in DDAPSS films revealed FeIII/II (-202 
mV) and FeII/I (-1082 mV) redox couples of the heme (pH 7).  Catalytic activity included 
dioxygen reduction by FeII, and reductive dehalogenation by FeI.  Voltammetry on hBM3 
in DDAPSS revealed that hBM3 and 1-12G display distinct redox properties.  Absorption 
spectra in solution showed the FeIII Soret at 418 nm for hBM3, and a split Soret for 1-
12G at 390 and 418 nm.  Voltammetry of the proteins within DDAPSS films revealed 
nearly identical FeIII/II potentials (~ -200 mV), but significant differences in ko, 250 vs. 30 
s-1, and FeIII/II – CO potentials, -140 vs. -115 mV, for hBM3 vs. 1-12G.  Catalytic 
dioxygen reduction by the proteins on RDEs was analyzed using Levich and Koutecky-
Levich treatments.  Calculated values of n, 2.7 vs. 4.7, and kobs, 1.4 x 106 vs. 1 x 105  
M-1s-1, for hBM3 vs. 1-12G suggest that the two proteins differ strikingly in their reaction 
with dioxygen. 
Using the prototypical cytochrome P450 CAM (CAM), we attempted to generate 
high-valent species of P450 in DDAB films.  Performing rapid-scan (50 V/s) 
voltammetry revealed a couple (E) at 831 mV.  E was not observed at scan rates less than 
30 V/s at room temperature; however, at 4oC E could be reversibly generated at 1 V/s.  E 
was found to be sensitive to imidazole in solution and to variations in pH, suggesting that 
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the redox reaction is occurring at the metal center (i.e., FeIV/III) rather than at the 
porphyrin macrocycle.  Electrolyses revealed that the electrochemically generated high-
valent species is only capable of performing S-oxidation, converting thioanisole to 
methyl phenyl sulfoxide.   
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Abbreviations: ET, electron transfer; P450, cytochrome P450; BM3, cytochrome P450 
from Bacillus megaterium; CAM, cytochrome P450 from Pseudomonas putida. 
 
Enzymes as Commercial Tools 
The field of biocatalysis is constantly growing as scientists continue to search for 
industrial catalysts with minimal environmental consequences.  In this regard, enzymes 
have already demonstrated their enormous commercial utility (e.g., in the synthesis of 
chiral compounds for use in pharmaceutical, agricultural, and food industries1).  
However, the relative complexity, instability, and (for some) slow reaction rates has 
limited the use of biocatalysts.  Despite these drawbacks, popular demand for cleaner 
synthetic schemes utilizing environmentally friendly (so-called “green”) catalysts will 
continue to fuel research into biological alternatives for chemical synthesis.    
The group of proteins known as oxidoreductases has received special attention 
from industry for its ability to perform regio- and stereospecific reactions under 
physiological conditions.  In vivo, oxidation reactions are critical for a broad range of 
biological processes, from hormone synthesis2,* to pro-drug activation.3,†  Certainly, 
capturing oxidoreductase activity in vitro would facilitate medicinal fields by aiding in 
drug discovery and elucidating in vivo drug interactions.4,5  In addition to medicinal 
chemistry, exploiting oxidoreductase activity would also greatly contribute to the stereo- 
and regiospecific synthesis of high-value molecules.  In particular, achieving selective 
oxidation of alkanes is of considerable interest and worth.6  While the inert nature of 
                                                 
* Hydroxylation of androgens to estrogens by oxidoreductases is essential for development of female sexual 
characteristics. 
† Site-specific hydroxylation of the anticancer pro-drug cyclophosphoamide is required to generate the bio-
active molecule 
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alkanes limits their use largely to combustion, selective functionalization results in 
molecules that can be used as building blocks for more complex structures.7,‡  
Oxidoreductase activity also has applications in bioremediation.8   
Typically, commercial chemical oxidations require the use of powerful catalysts 
(e.g., CrVI, MnVII).  Use of such catalysts has several drawbacks, including uncontrolled 
(over-) oxidation, poor regio- and stereoselectivity, toxicity (requiring proper handling 
and disposal), poor efficiency, and various side reactions.9,10  Indeed, the harsh conditions 
required to drive these chemical conversions can also lead to degradation of the desired 
products (particularly true for medicinal compounds that likely have multiple 
functionalities).  Thus, biocatalytic oxidation systems seem to be the clear choice for 
achieving selective oxidations.  Unfortunately, exploiting oxidoreductase activity for 
commercial and medical applications has proven difficult, due in large part to the 
complexity of biological systems.  For many oxidoreductases, this complexity often 
includes lengthy electron transfer (ET) chains that utilize several intermediate proteins 
and cofactors, each of which makes a specific interaction in order to achieve the required 
ET for subsequent catalysis.  Consequently, these enzymes have realized only a small 
fraction of their potential. 
 
The Cytochromes P450: Potential Tools 
The superfamily of enzymes called cytochromes P450 (P450s) are heme-
containing oxidoreductases that perform highly regio- and stereospecific reactions under 
physiological conditions.  First discovered in 1960, to date more than 500 different P450s 
                                                 
‡ As an example, hydroxylated alkanes can be used to synthesize surfactants.  The physical and chemical 
properties of the surfactant will be entirely dependent on the site of oxidation and the nature of the 
subsequent chemical modifications. 
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have been identified, cloned, and sequenced, resulting in a plethora of information on 
P450 structure, function, and biochemistry.11-13  The diverse repertoire of reactions 
catalyzed by P450s is shown in Table 1.1.  The hallmark reaction of this enzyme class is 
catalytic hydroxylation of hydrocarbons: 
R-H  +  NAD(P)H  +  H+  +  O2    →    R-OH  +  NAD(P)+  +  H2O 
In vivo, P450s are critical for the biosynthesis of various hormones, eicosanoids, 
and prostaglandins.5  In addition to catabolism, P450s also perform crucial oxidation 
reactions that determine the ultimate fate of many drugs and xenobiotics; for example, 
human microsomal P450s are known to metabolize more than 90% of all marketed 
drugs.14  In vitro, P450s are capable of catalyzing many industrially valuable oxidation 
reactions, converting inert hydrocarbons into alcohols and ketones that can be used as 
precursors for more complex molecules.6   
Broadly, P450s can be divided into two categories, mammalian and bacterial.  
Key differences between the two forms are found in solubility and electron transfer 
partners. Bacterial forms are soluble proteins that receive electrons from cytosolic 
ferredoxins (Fe-S proteins) and ferredoxin reductases.  In contrast, mammalian forms are 
membrane-bound, and are reduced by membrane-associated flavin-containing reductases.  
In addition to these differences, the two classes also display low sequence identity (e.g., 
16% amino acid identity between human cytochrome P450 1A2 and bacterial P450 
BM315); indeed, even closely related P450s are known to be somewhat divergent in 
sequence (e.g., 63% amino acid identity between Bacillus P450 homologs 102A1 and 
102A216).  Despite this low sequence identity, all P450s do share a similar overall fold.  
Most contain heme domains that are 40-60 kDa with an approximate triangular prism 
P450
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shape.  In particular, the structure around the heme is known to be highly conserved, with 
all P450s possessing a thiolate ligand in the heme iron proximal coordination site.   
Mechanism 
The characteristic common to all P450s is the Soret band at ~ 450 nm of the  
FeII – CO  complex, which is diagnostic of a cysteinate ligand bound to the heme iron in a 
trans orientation relative to the carbon monoxide ligand.17  Thiol ligation to the heme iron 
is postulated to be the critical factor that separates P450-type reactivity from other heme 
proteins (like myoglobin, which has a histidine-ligated heme) by modulating the heme 
redox properties to activate dioxygen for substrate oxidation.18  Indeed, mutating this 
cysteine to another amino acid abolishes the unique chemistry catalyzed by P450.19   
The scheme shown in Figure 1.1 represents the generally accepted catalytic 
mechanism for P450.12  The resting state is the six-coordinate low spin FeIII (Eo between  
-330 and -370 mV vs. NHE, depending on the P450), with the porphyrin occupying the 
four planar positions and the axial positions occupied by a cysteine (proximal) and water 
(distal).  Catalysis is initiated by substrate binding in the protein active site and 
displacement of the axial water, causing the six-coordinate low spin FeIII to convert to 
five-coordinate high spin FeIII.  This shift in spin state is accompanied by a change in 
heme potential (substrate-dependent, but generally greater than +100 mV), which has 
been shown to initiate ET to the heme from native reductase proteins.20  Reduction to FeII 
allows dioxygen to bind to the iron, forming the FeII – O2 complex.  A second reduction 
followed by protonation creates the peroxy complex, FeIII – OOH-, which is further 
protonated to yield a molecule of water and a high valent iron-oxo complex.  The nature 
of this iron-oxo complex, formally referred to as compound I, is not definitively known.  
1-6 
Currently, there is no solid experimental evidence for the precise identity of this species.  
Two possibilities are generally considered: one is FeV = O, while the other is  
FeIV = O(P+), where P+ represents a porphyrin cation radical.  Whatever the true nature of 
compound I, it is believed that this species is responsible for substrate oxidation, 
producing the oxidized product and regenerating the P450 resting state. 
Notably, an alternative catalytic pathway termed the “peroxide shunt” also exists.  
In this pathway, reduced dioxygen is supplied in the form of peroxide, which can enter 
the catalytic cycle and directly generate the FeIII – OOH- complex in Figure 1.1.   
 
Electrons and P450 
NAD(P)H 
Arguably, the key to the catalytic mechanism in Figure 1.1 is ET.  In vivo, the 
ultimate source of electrons for P450 catalysis is NAD(P)H: this requirement for 
NAD(P)H is perhaps the greatest obstacle standing in the way of commercial use of 
P450s for selective oxidations.  NAD(P)H is expensive, decomposes over time, and is 
difficult to recover once oxidized.  This has resulted in several investigations aimed at 
regenerating NAD(P)H.  The most obvious regeneration method is to utilize an electrode.  
However, electrochemical regeneration of NAD(P)H proceeds through two one-electron 
transfer steps, which competes unfavorably with a pathway that forms biologically 
inactive dimers between the one-electron reduced form of the cofactor.21  Chemical 
reductants for NAD(P)H have the additional drawback of either not being reusable or 
requiring regeneration themselves (which would typically utilize a negatively polarized 
electrode that can lead to NAD(P)H dimers).22  Enzymatic recycling systems provide an 
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efficient way of regenerating NAD(P)H in vitro,23 but having additional proteins in the 
system introduces several problems: 1) optimal conditions for the different proteins may 
not be compatible; 2) having other enzymes in solution could lead to unforeseen 
competing reactions; 3) additional reaction components can lead to greater difficulty in 
recovering the products.  Finally, in vivo recycling systems that utilize whole-cell 
machinery for NAD(P)H regeneration usually suffer from poor reaction rates, in addition 
to the usual problems associated with whole-cell reactions (e.g., poor cell permeability of 
substrates/products, poor product recovery).24 
Direct P450 Electrochemistry 
An alternative approach for supplying reducing equivalents to P450 bypasses the 
NAD(P)H requirement altogether by delivering electrons to the protein directly with an 
electrode.  Generally, direct protein electrochemistry has proven difficult: the intervening 
peptide medium results in relatively weak electronic coupling between buried cofactors 
and external reductants.25-27  For P450, the heme is buried deep within the polypeptide, 
which means that success of an electrochemical method is going to depend on finding a 
way to increase electronic coupling between the heme and the electrode.  Notably, direct 
electrochemistry at an unmodified edge-plane graphite electrode has been achieved with 
P450 from Pseudomonas putida (CAM); however, the study revealed that the system 
displayed poor electronic coupling, as evidenced by the slow and quasi-reversible ET.28   
A survey of the available literature reveals several techniques for direct 
electrochemical reduction of P450.  The first, and perhaps most general method for P450 
reduction at an electrode utilizes surfactant films to confine the protein to the electrode 
surface.29,30  The surfactant forms bilayers and micelles on the electrode, and has been 
1-8 
shown to provide a favorable environment for ET to the P450 heme.  A second, similar 
method utilizes polyelectrolyte films that are co-adsorbed with P450.31,32  Both types of 
films result in good electronic coupling, with standard rate constants (ko, ∆Go = 0) 
typically between 100 - 300 s-1.  The ability of these films to electronically couple the 
P450 heme to the electrode has been rationalized in the following ways: 1) the films 
block adsorption of contaminants that would foul the electrode surface; 2) the films 
provide an environment that retains the native protein conformation at the surface, 
preventing non-specific adsorption and denaturation.33  In both film systems, 
immobilized P450s were able to catalytically epoxidize styrene to styrene oxide (1 - 6 
mols substrate / mols enzyme / hr).  The mechanism was found to operate through the 
peroxide shunt, with peroxide being generated from electrochemically-mediated P450-
catalyzed dioxygen reduction.   
The third successful method achieved electrochemistry with CAM by using 
sodium montmorillite (carbon-based polyanionic clay) to coat the surface of an 
electrode.34  The anionic clay was proposed to interact electrostatically with a region on 
the surface of CAM that was positively charged; this region is also presumed to be the 
binding site of the native reductase for CAM.  Rapid, reversible ET was observed (ko 
approximately 150 s-1), as well as catalytic reduction of dioxygen.  However, substrate 
turnover was not reported.   
A fourth method for electrochemical P450 reduction utilized self-assembled 
mercaptan films on gold to achieve ET with mammalian P450 2E1.35  Indeed, alkanethiol 
monolayers on gold electrodes are commonly used to provide surfaces that interact 
favorably with various proteins to achieve ET.36  For P450 2E1, the critical step was to 
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further derivatize the gold-mercaptan surface, using either maleimide or 
poly(diallyldimethylammonium chloride); without this second coating, ET was not 
observed.  While electronic coupling was not as efficient as the aforementioned systems 
(ko between 2 and 10 s-1), catalytic substrate oxidation was observed.  Although this type 
of system is not practical for large-scale substrate turnover,§,37 it shows promise for 
biosensing. 
Finally, Shumyantseva et al. reported a technique where they covalently attached 
a synthetic flavin cofactor to the surface of two mammalian P450s, 2B4 and 1A2.38  The 
flavin was meant to act as an electronic relay, mimicking the contact that the natural 
reductase would make with the heme domains.  Reduction of the flavin at the electrode 
resulted in ET through the protein sheath and into the heme.  Although ET rates were not 
reported, they did report catalytic rates of approximately 1 nmol product / nmol enzyme / 
minute (similar to reactions conducted with NAD(P)H).  Drawbacks of this system 
include the slow rates and the need for covalent modification of the protein. 
Clearly, P450 electrochemistry is not straightforward.  Electrode or protein 
modifications are often required to achieve the desired ET.  In addition, as demonstrated 
in the examples above, achieving good electronic coupling will not necessarily produce 
systems competent for catalytic substrate oxidation, while those that are catalytic 
generally do not function at practical rates.   
 
 
 
                                                 
§ There are several difficulties with scaling up this system, most of which are related to properly preparing 
the gold surface.  See Tanimura et al for a discussion on this. 
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Cytochrome P450 BM3 
 
Of the numerous P450s, the variant isolated from the bacterium Bacillus 
megaterium (BM3) is a good candidate for commercial applications.  Credit goes to 
Fulco’s group at UCLA for initially identifying and characterizing BM3.39,40  The protein 
is comprised of a heme domain and a flavin-containing reductase domain fused together 
on a single polypeptide chain.  The enzyme catalyzes the sub-terminal hydroxylation of 
long-chain fatty acids (10-16 carbons), and has catalytic rates up to 1000 times faster than 
most other P450s.  BM3 possesses several ideal characteristics for biocatalysis: the 
enzyme 1) is soluble; 2) can be expressed in large quantities in E. coli; 3) has relatively 
broad substrate specificity, while 4) mutants of BM3 are even more active and have 
broader substrate specificity;6 5) has a partial crystal structure available;41 6) can be 
easily assayed for activity.42 
Structure 
 BM3 is 119 kDa and consists of two domains: 1) a reductase domain (66 kDa) at 
the carboxy end of the polypeptide contains FAD and FMN cofactors, and is responsible 
for mediating ET from NADPH in solution to the heme domain; 2) an amino-terminal 
heme domain (55 kDa) that contains protoporphyrin IX with FeIII (resting state) in the 
cavity.43  This arrangement makes BM3 more similar to mammalian P450s, which utilize 
flavin containing reductases, than to the ferredoxin-mediated bacterial variants.  Indeed, 
based on sequence identity, BM3 shows greater similarity to the eukaryotic P450s.  The 
primary amino acid sequence of the BM3 reductase and heme domains are approximately 
35% and 30% identical to their eukaryotic microsomal counterparts, while the bacterial 
forms share as little as 15% identity with BM3.41  The similarity of BM3 to the little-
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understood mammalian P450s has led many to consider it a good candidate for modeling 
the eukaryotic variants.44   
To date, the crystal structure of the full-length BM3 has not been solved.  
However, crystal structures of the heme domain41 and the heme domain complexed with 
the adjacent FMN domain45 do exist.  Figure 1.2 shows the crystal structure of the BM3 
heme domain with N-palmitoylglycine (yellow) bound in the active site over the heme 
(red).46  In the absence of substrate, the distal axial position is occupied by a water 
molecule coordinated to the heme iron.  The protein is approximately 65 Å in diameter.  
The heme lies deeply buried within the protein matrix, with no part of it directly exposed 
to bulk solvent.  The active site is accessible to external molecules through a long 
substrate access channel, ~ 8-10 Å, lined mostly with non-aromatic, hydrophobic amino 
acids.  In Figure 1.2, this channel is occupied by the tail end of N-palmitoylglycine.   
Several key amino acid residues have been identified in the BM3 heme domain 
(Figure 1.2).  Most notably, Cys400 ligates the heme iron directly and, as described 
above, is responsible for the unique oxidation chemistry catalyzed by all P450s.  Phe87 
lies directly over the heme and is one of the most extensively characterized amino acids 
in BM3.  When substrate binds, Phe87 “flips” from a horizontal to a perpendicular 
orientation relative to the heme.47  This residue has a significant effect on the peroxide 
shunt activity of BM3: while the wild type enzyme has no activity with the peroxide 
shunt, mutating Phe87 to smaller amino acids (most notably F87A) has been shown to 
confer shunt acitivity.48  A third important amino acid is Phe393, which has been shown to 
have a significant effect on the heme redox potential.  Mutating Phe393 to other amino 
acids resulted in variants with significantly altered heme reduction potentials, electron 
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transfer rates, and catalytic rates.49  Finally, Thr268 has been shown to be conserved 
throughout the P450 superfamily and is thought to play a critical role in the catalytic 
cycle by providing protons for dioxygen reduction (ultimately to water) by the heme.41   
Redox Chemistry and Electron Transfer 
ET in BM3 begins with NADPH in solution (Eo = -340 mV vs. NHE) transferring 
hydride to the FAD in the reductase domain.20   A single electron is then transferred to 
the second flavin in the reductase, FMN, resulting in semi-quinone forms of each flavin.  
Reduction of the heme by the FMN semi-quinone can only occur with substrate bound: 
substrate binding converts the heme from low spin (Eo = -370 mV) to high spin (Eo 
approximately -250 mV), with the resulting shift in potential now favoring ET from the 
FMN semi-quinone to the heme.  The second electron in the FAD is then transferred to 
the FMN, which in turn reduces the heme a second time at the appropriate moment 
according to the scheme in Figure 1.1. 
The crystal structure of the heme domain complexed with the FMN domain is 
shown in Figure 1.3.  Since the inter-domain contact forms the relevant complex for ET 
between the FMN (blue) and the heme (red), the structure in Figure 1.3 provides key 
insights into the native ET pathway in BM3.  As mentioned above, the heme is deeply 
buried within the protein matrix.  Isolation of the heme in this way would make it 
difficult for an external source to reduce the iron, as is required for P450 oxidation 
chemistry.  Thus, proper positioning and docking of the FMN domain directly underneath 
the heme is likely to be crucial for efficient ET. 
Unlike the CAM-ferredoxin docking interaction, where electrostatics are the key 
force driving proper orientation of the two domains for ET,50 BM3 likely uses a 
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combination of forces.  Electrostatic interaction between the two domains is proposed to 
be relatively weak: analysis of the structure revealed two direct hydrogen bonds, one salt 
bridge (His100 and Glu494), and several water-mediated contacts.45  Given that the contact 
interface spans some 967 Å2, these relatively few electrostatic interactions suggest that 
these forces contribute minimally.  Most likely, the electrostatics act in combination with 
the orientation effect supplied by the short peptide linker between the heme and FMN 
domains to synergistically orient the two for ET.  Indeed, reconstitution experiments that 
utilize separately expressed reductase and heme domains result in poor substrate turnover 
rates in the presence of NADPH.51 
The isoalloxazine ring of the FMN has its methyl groups pointing directly to the 
heme binding loop (residues 382 – 400, highlighted in yellow in Figure 1.3); without the 
heme domain, this part of the FMN would be solvent-exposed.  Thus, the methyl groups 
likely act as a bridge, providing an inter-domain pathway for ET.  Indeed, distance 
calculations put the 7-methyl group at only 4 Å from the amide nitrogen of Gln387.45  It 
has been suggested that this precise positioning indicates the two domains form a specific 
complex for ET.   
 
Objective: NADPH Alternatives for BM3 
 In summary, exploiting P450 oxygenase activity would greatly facilitate many 
areas of fundamental medical research and have invaluable potential in industrial 
processes.  BM3 in particular possesses many of the characteristics that the ideal P450 
biocatalyst should have.  However, the need for reducing equivalents from NADPH will 
continue to hinder practical uses of BM3.  The NADPH requirement is best dealt with by 
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finding alternative sources of electrons; this can be accomplished with a reductant that 
can transfer electrons through the reductase to the heme, or by utilizing a method that 
delivers electrons directly to the heme, thereby eliminating the reductase domain.  The 
principal question explored in this thesis can now be stated: how can we efficiently 
deliver an electron from an external source, either from a soluble reductant or directly 
from an electrode, through the protein sheath and to the heme in a fashion that 
sufficiently mimics the native system in order to achieve catalytic substrate oxidation?  
The pages that follow describe efforts to utilize an electrode as the ultimate source of 
electrons for BM3 catalysis, providing lessons and insights for in vitro electrochemical 
systems exploiting P450 oxidative catalysis. 
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Table 1.1.  P450-catalyzed reactions. 
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Figure 1.1.  The canonical mechanism of cytochrome P450 is shown. 
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Figure 1.2.  The crystal structure of the cytochrome P450 BM3 heme domain is shown.  
The substrate N-palmitoylglycine (yellow) is bound in the substrate access channel 
directly above the heme (red).  Key amino acids (blue) are labeled. 
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Figure 1.3.  The crystal structure of the cytochrome P450 BM3 heme domain complexed 
with the native FMN domain is shown.  The heme (red) and FMN (blue) cofactors are 
presumed to be electronically coupled through the 382 – 400 peptide loop (yellow). 
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Chapter 2 
 
Cobaltocene-Mediated Catalytic Monooxygenation Using Holo and Heme Domain 
Cytochrome P450 BM3* 
 
 
 
 
 
 
 
*Adapted from Udit, A. K.; Arnold, F. H.; Gray, H. B. J. Inorg. Biochem. 2004, 98, 1547-
1550. 
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Abstract 
The feasibility of replacing NADPH with 1,1’-dicarboxycobaltocene in the catalytic 
cycle of cytochrome P450 BM3 has been explored.  Using the holoprotein, the surrogate 
mediator was observed to reduce both the FAD and FMN in the reductase domain, as 
well as the iron in the heme domain.  In an electrochemical system, the mediator was able 
to support lauric acid hydroxylation at a rate of 16.5 nmol product / nmol enzyme / 
minute.  Similar electron transfer and catalysis were observed for the heme domain alone 
in the presence of the metallocene; the turnover rate in this case was 1.8 nmol product / 
nmol enzyme / minute.  Parallel studies under the same conditions using a previously 
reported cobalt sepulchrate mediator showed that the two systems give similar results for 
both the holoenzyme and the heme domain. 
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Abbreviations: BM3, flavocytochrome P450 BM3; ET, electron transfer; Co(sep), 
cobalt(III) sepulchrate; Mox, 1,1’-dicarboxycobaltocenium hexafluorophosphate; Mred, 
1,1’-dicarboxycobaltocene; hBM3, heme domain P450 BM3 
 
Introduction 
The ability of the cytochromes P450 to catalyze challenging oxidation reactions 
under physiological conditions has made them attractive targets for in vitro 
applications.1,2  Of the P450s, flavocytochrome P450 from Bacillus megaterium (BM3) is 
particularly appealing for commercial use, owing to its ease of handling and the ability to 
create mutants with altered substrate specificity.3(and references therein)  Capturing BM3 activity 
in vitro would be greatly facilitated if reductants other than NAD(P)H could be found.  
One way to replace NADPH in the catalytic cycle of BM3 would be to use the holo 
protein in an electrochemical system that employed a small molecule mediator as an 
electron shuttle.  The mediator, after transferring electrons to the BM3 reductase domain, 
would be regenerated at the electrode.  Electron transfer (ET) through the protein can 
then occur via the native pathway, FAD → FMN → heme, culminating in catalytic 
substrate oxidation.   
Among the investigations seeking alternative reductants for P450,4,5 the most 
successful utilized a platinum electrode and cobalt(III) sepulchrate (Co(sep)) as the 
electron shuttle (Figure 2.1a).6  Co(sep) is a water soluble cobalt cage complex that has a 
CoIII/II redox couple at -550 mV (vs. Ag/AgCl).  Co(sep)-mediated catalysis was 
demonstrated with a variety of P450s, with rates approaching that of NAD(P)H-driven 
systems (for BM3 with lauric acid, 110 min-1 cf. 900 min-1 for Co(sep) cf. NADPH).6  
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However, practical limitations of the Co(sep) system include production of reactive 
oxygen species,7 difficulty in synthetically manipulating Co(sep) to tune the mediator to 
different reaction conditions (e.g., solvent, pH), and aggregation and precipitation at 
functional Co(sep) concentrations (typically, 1-10 mM).8  
We endeavored to find a better mediator for BM3.  Previous work with glucose 
oxidase utilized a ferrocene derivative to mediate enzyme oxidation,9 demonstrating the 
idea of designing a mediator for a given application.  For BM3 reduction, we decided to 
use the analogous reductant cobaltocene as a scaffold to construct a suitable mediator.  In 
the hope that the dicarboxy derivative of cobaltocene could improve water solubility and 
disfavor aggregation, as well as raise the redox potential so the mediator would not be as 
air-sensitive, we synthesized 1,1’-dicarboxycobaltocenium hexafluorophosphate (Mox) 
(Figure 2.1b) and evaluated this molecule for its efficacy as a mediator for 
bioelectrochemical catalysis with BM3.   
 
Results and Discussion 
The synthetic scheme for Mox is shown in Scheme 2.1.  At physiological pH (7-
8), the carboxyls are fully deprotonated,10 greatly enhancing water solubility.  Cyclic 
voltammetry with a glassy carbon electrode in 0.1 M phosphate buffer pH 8 revealed that 
the CoIII/CoII couple is fully reversible with an E1/2 of -830 mV (vs. Ag/AgCl); this value 
is 320 mV more positive than that of unmodified cobaltocene, owing to the electron 
withdrawing nature of the carboxyl groups.  Chemical reduction to the active CoII form, 
1,1’-dicarboxycobaltocene (Mred), was achieved with zinc dust.   
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Absorption spectra were recorded to observe flavin reduction by the putative 
mediator.  The flavins are the most readily reduced centers: FAD is rapidly reduced by 
soluble reductants (e.g., NADPH), and ET between the two flavins is fast.11  In Figure 
2.2, the shoulder between 440 and 490 nm is characteristic of oxidized flavins in BM3;12 
this shoulder disappears upon reduction by NADPH.  As can be seen from Figure 2.2, 
adding Mred to a solution of BM3 results in a spectrum similar to that obtained after 
adding NADPH.  This confirms flavin reduction by Mred, and suggests that Mred can 
indeed function in place of NADPH. 
Addition of Mred to a solution of BM3 saturated with CO gave a peak at 448 nm 
(Figure 2.3), characteristic of the FeII-CO species.13  Notably, heme reduction by Mred 
occurs in the absence of substrate, unlike in the native system where ET from flavins to 
the heme requires substrate at the active site.14  Substrate displaces water from the heme 
pocket, converting FeIII from low to high spin.  This conversion is accompanied by a 
positive shift in the heme potential (> 100 mV) that favors ET from FMN to the heme.  It 
appears that Mred reduces the heme directly, bypassing the reductase pathway.  To test 
this, Mred was added to a CO-saturated solution of the isolated BM3 heme domain 
(hBM3).  As can be seen in Figure 2.3, the Soret band at 448 nm shows that Mred reduced 
the heme iron.  The hydrophobic substrate access channel15 and the -2 charge on Mred 
make it unlikely that heme reduction occurs by direct interaction of the mediator with the 
active site.  Apparently, Mred takes an alternative ET pathway, thereby opening the way 
for catalysis without the reductase domain.   
Enzyme activity assays were performed with lauric acid (Km = 100 µM with 
BM316).  Thirty-minute reactions in air were conducted with 1 µM BM3 or hBM3, 1 mM 
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lauric acid, and 1 mM reductant (Mred or NADPH) in a final volume of 1 mL at room 
temperature.  The reactions were quenched with 5 drops of concentrated HCl, and then 
samples were prepared for GC/MS analysis as described.17  Negative controls lacking one 
component (substrate, mediator, or enzyme) were also carried out.  The negative controls 
gave no product, while the NADPH and Mred samples for both BM3 and hBM3 yielded 
the expected hydroxylated compounds.  The resulting product distribution of the Mred 
reactions, 36:28:36 for ω-1:ω-2:ω-3 hydroxy laurate, was similar to that of the NADPH-
driven reaction.16  To test if the observed products are a consequence of the peroxide 
shunt (from oxygen reduction to peroxide by Mred), reactions with Mred were also carried 
out in the presence of catalase.  The resulting product profile was similar to that without 
catalase,† indicating that the reaction was metallocene-mediated: this was expected as 
previous work has shown that wild type BM3 does not have significant peroxide shunt 
activity.17   
Next, we developed an electrochemical system where the soluble mediator 
provides electrons to the enzyme and is continuously regenerated at an electrode.‡  
Co(sep) reactions were run in parallel with Mred reactions in order to compare the two 
mediators.  The results in Table 2.1 reveal that the two mediator systems perform 
similarly under the conditions used.  Notably, the rate shown in Table 2.1 for Co(sep) 
with BM3 is less than that previously reported (38 vs. 110 min-1); this probably results 
from continuously bubbling air into solution, which removes both dioxygen and the 
mediator from the reaction as they react with one another.  The hBM3 results are 
intriguing: to our knowledge, this is the first report of mediated electrochemical catalysis 
                                                 
† See Experimental Methods for details of the catalase control reaction. 
‡ See Experimental Methods for details of the electrochemical reaction setup. 
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with the heme domain.  Although the reaction proceeds slowly, it nevertheless occurs and 
opens the possibility of performing the reaction with the heme domain alone, which could 
be advantageous given the propensity of the reductase to become inactivated through 
over-reduction.14   
The difference in rate between the mediated reactions and the native system can 
be partially understood by examining the current function.  A typical current function 
from an Mox-BM3 reaction is shown in Figure 2.4.  Initially, the reaction solution 
contains only Mox.  Applying a reducing potential results in a current that decays from an 
initial value of 4 mA to one that is near zero as Mox is converted to Mred.  Addition of the 
oxygenated enzyme-substrate solution followed by bubbling air into the reaction causes a 
spike and subsequent limiting current of 3 mA.  From this limiting current, the coupling 
between total current passed by the electrode and total product formed can be calculated:§ 
this yields a coupling efficiency of only 2% for the Mred-BM3 bioelectrochemical system.  
A similar calculation for hBM3 reactions yields only 0.3%.  These poor efficiencies attest 
to the acute sensitivity of cobaltocene to dioxygen.18  Bubbling air into the reaction leads 
to rapid Mred oxidation, removing both dioxygen and the reduced mediator from the 
reaction as it becomes substrate limited; this undoubtedly contributes to the difference in 
rate between the mediated and native systems.   
 
 
                                                 
§ Using the limiting current, the coupling between product formation and total charge passed can be 
calculated.  From Table 2.1, 224 nmols of product are formed in the BM3 reaction.  From Figure 2.4, the 
total charge passed by the electrode during the biocatalytic reaction at the onset of the limiting current is 
2.7 Coulombs.  Applying the Faraday constant, the degree of coupling is calculated as the number of moles 
of product divided by half the number of moles of electrons (two electrons per product). 
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Summary 
In conclusion, we have shown that the dicarboxy derivative of cobaltocene can 
function as an electrochemical mediator of P450 catalytic reactions.  The main limitation 
of the Mox system is its poor coupling efficiency, owing largely to the sensitivity of Mred 
to dioxygen.  Although the overall kinetics and turnover of Co(sep) with P450 are 
slightly better,  Mox can be modified more readily to optimize reaction parameters, 
providing a more versatile mediator.   
 
Experimental Methods 
Protein Expression 
Expression, purification, and quantification of BM3 and hBM3 for use with the 
mediator were performed as described.17   
Synthesis of 1,1’-dicarboxycobaltocenium hexafluorophosphate (Mox) 
Lithium methylcyclopentadienide (LiMeCp) and cobalt(II) acetylacetone (2:1 
molar ratio) were added to THF in a dry ice/acetone bath under argon.  The mixture was 
left to stir overnight at room temperature.  The solvent was removed under vacuum, and 
the dark brown product Co(II)(MeCp)2 was isolated by sublimation for 2 hours at 85oC.  
The product was mixed with AgPF6 (1:1 molar ratio) and was left overnight to stir in 
CH2Cl2 under argon at room temperature.  After filtering the solution to remove the 
silver, the solvent was removed under vacuum, leaving behind the yellow-green product 
Co(III)(MeCp)2PF6.  This product was mixed with NaOH pellets and KMnO4 (1:2:3 
molar ratio, respectively).  The mixture was refluxed in water for 4 hours, filtered hot 
through Celite, and an equimolar amount (cf. Co(III)(MeCp)2PF6) of NaPF6 was added.  
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The solvent was then removed on a rotovap and the solid was washed repeatedly with 
acetone.  The final product, Co(III)(CpCOOH)2PF6 (Mox), was a bright yellow powder 
(λmax = 410 nm).   
Chemical reduction was achieved by adding 500 mg of zinc dust to 15 mg of Mox 
and 8 mL of degassed buffer (25 mM Tris hydroxymethylaminoethane-HCl, 25 mM 
potassium phosphate, 250 mM KCl, pH 8.0).  This mixture was stirred under argon for 4 
hours and then filtered to remove the zinc dust.  The result was a dark red solution (λmax = 
490 nm) of Mred solubilized in a buffer that could be readily used in an enzymatic 
reaction.   
Catalase Control 
 Analogous to the reaction conditions described in the main text, a thirty-minute 
reaction in air was conducted with 1 µM BM3 or hBM3, 1 mM lauric acid, and 1 mM 
reductant (Mred) in a final volume of 1 mL that also contained 2 µL of a 2.42 x 103 
Unit/µL solution of catalase.  The reaction was conducted at room temperature.  The 
sample was then prepared for analysis by GC/MS17 (described in detail in the next 
section).  The product profile was found to be similar for reactions with or without 
catalase.  Negative controls (reactions lacking either enzyme, metallocene, or substrate) 
did not result in any observable products. 
Bioelectrochemical Cell 
All electrochemical reactions were carried out at room temperature.  A mini-
bioreactor was constructed using a stirred two-compartment cell, separating the working 
and Ag/AgCl reference electrodes from the Pt wire auxiliary with a glass frit.  The 
working electrode was a 2 cm x 2 cm carbon cloth (ElectroChem, Inc.) that covered the 
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bottom of the cell.  A CH Instruments Electrochemical Workstation consisting of a 
potentiostat and software was used for the electrochemical reactions.  The cell was first 
purged with a stream of argon, which was left on during the entire reaction.  To the 
sample chamber, 2 mL of degassed buffer (170 mM KCl, 10 mM MgCl2, 57 mM Tris-
HCl pH 7.4) were added, as well as 2 mL of a degassed 5 mM solution of mediator (Mox 
or Co(sep)) in the same buffer.  4 mL of degassed buffer were also added to the auxiliary 
chamber.  A potential of -0.9 V was applied, and the mixture was stirred for 6 minutes.  
At this point, 1 mL of a solution containing protein and 5 mM lauric acid were added to 
the working chamber, and air was bubbled into the reaction at a rate of 1 bubble/second 
using a Pasteur pipette.  Final concentrations and volumes were 1 mM lauric acid, 2 mM 
mediator, 1 µM BM3 or 1.5 µM hBM3, and 5 mL reaction volume.   
Determination of Enzyme Activity in the Electrochemical System 
0.5 mL aliquots were removed from the electrochemical cell at various time 
points and added to 3 drops of concentrated HCl to quench the reaction.  The samples 
were then prepped for analysis using GC-FID as described.17  Briefly, 5 µL of 50 mM 10-
OH capric acid in DMSO (internal standard, described below) were added, and the 
reactions were then extracted three times with an equivolume of ethyl acetate.  The ethyl 
acetate extracts were dried with sodium sulfate, followed by evaporation under vacuum.  
The samples were derivatized by adding 100 µL of a 1:1 mixture of pyridine:BSTFA, and 
then incubating at 80oC for 20 minutes.  2 µL of these samples were then injected into the 
GC-FID with an HP-5 column.   
A calibration curve was created to quantify the amount of product formed.  Wild 
type BM3 sub-terminally hydroxylates lauric acid at the ω-1, ω-2, and ω-3 positions.16 
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Since authentic standards for these compounds are not available, 12-OH-lauric acid was 
used to make the calibration curve with the assumption that the position of the hydroxyl 
group does not affect the FID response.  An internal standard, 10-OH-capric acid, was 
used to aid quantification by adding a known amount to the samples, and then correlating 
the relative areas of 12-OH- to 10-OH-laurate to the amount of 12-OH-laurate initially 
present.   
The reported rates in Table 2.1 were sustained for the initial 10 minutes of the 
reaction, after which a decrease in rate was observed (likely due to enzyme denaturation 
from excessive bubbling of air into solution).  Total turnover numbers were determined 
after 45 minutes of reaction, after which it was found that no further significant turnover 
occurred.   
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Table 2.1.  Rates and total turnovers for the electrochemical biocatalytic reactions.   
 
 
 
Enzyme 
 
Mediator 
Rate 
(nmol product / nmol 
enzyme / min) 
Total Turnover 
(nmols product / 
nmols enzyme) 
 
BM3 Cobaltocene cation 16.4 ± 0.6 224 ± 7 
BM3 Cobalt(III) sepulchrate 37.8 ± 0.3 835 ± 7 
hBM3 Cobaltocene cation 1.8 ± 0.5 58 ±  7 
hBM3 Cobalt(III) sepulchrate 2.2 ± 0.1 76 ± 7 
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Scheme 2.1.  Synthesis of 1,1’-dicarboxycobaltocenium hexafluorophosphate (Mox). 
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Figure 2.1.  Structures of (a) cobalt(III) sepulchrate and (b) 1,1’-dicarboxycobaltocene 
cation. 
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Figure 2.2.  BM3 absorption spectra (oxidized and reduced proteins): the shoulder 
between 440 and 490 nm attributable to oxidized flavins disappears upon reduction by 
NADPH and Mred. 
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Figure 2.3.  Spectra of both holo (BM3) and heme domain (hBM3) BM3 in the presence 
of carbon monoxide and Mred:  the peaks at 448 nm indicate heme reduction by Mred and 
formation of an FeII-CO complex.  
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Figure 2.4.  Current versus time for the electrochemical biocatalytic reaction:  the initial 
decay represents anaerobic electrochemical reduction of Mred; this decay is followed by a 
spike in the current resulting from addition of oxygenated enzyme-substrate solution; a 
steady-state condition is established after 600 s (plateau region). 
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Chapter 3 
 
Pyrene-Wired Heme Domain Cytochrome P450 BM3 Electrodes* 
 
 
 
 
 
 
 
 
*Reproduced in part with permission from J. Am. Chem. Soc. 2004, 126, 10218-10219.  
Copyright 2004 American Chemical Society. 
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Abstract 
We have electronically wired the cytochrome P450 BM3 heme domain through 
surface Cys387 to a graphite electrode with the use of a pyrene-terminated tether.  AFM 
images clearly reveal that pyrene-wired enzyme molecules are adsorbed to the electrode 
surface.  The enzyme-electrode system undergoes rapid and reversible electron transfer, 
displaying a standard rate constant higher than that of any other P450-electrode system.  
We also show that the graphite-pyrene-BM3 system catalyzes the four-electron reduction 
of dioxygen to water.  Analogous experiments were also conducted with enzyme labeled 
at Cys62, which is situated spatially adjacent to Cys387 but does not provide a similar well-
coupled through-bond pathway to the heme.  Surprisingly, the Cys62 mutant showed 
similar electrode kinetics.  This demonstrates that the pyrene tether does not provide a 
unique through-bond pathway, but rather anchors the protein onto the electrode surface in 
a favorable docking mode for rapid heme reduction. 
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Abbreviations: P450, cytochrome P450; ET, electron transfer; BM3, cytochrome P450 
from Bacillus megaterium; Py, N-(1-pyrene)iodoacetamide; BPG, basal plane graphite; 
hBM3, cytochrome P450 BM3 heme domain; AFM, atomic force microscopy; RDE, 
rotated-disk electrode; 12-pNCA, 12-p-nitrophenylcarboxylic acid; pNP, p-nitrophenol; 
HOPG, highly-oriented pyrolytic graphite 
 
Introduction 
The cytochromes P450 (P450s) are ubiquitous heme monooxygenases that 
catalyze a wide range of reactions under physiological conditions.1  The value of their 
oxidative activity in both fine chemicals (e.g., alkane hydroxylation) and medical (e.g., 
pro-drug activation) industries has fueled research into capturing this activity in vitro.  Of 
the P450s, flavocytochrome P450 from Bacillus megaterium (BM3) is particularly 
appealing for commercial use, owing to its ease of handling and the ability to create 
mutants with altered substrate specificity.2   
Exploiting BM3 activity in vitro would be greatly facilitated if reductants other 
than NADPH could be found.  While an electrode is perhaps the most attractive source of 
electrons, direct BM3 electrochemistry has been elusive, owing largely to poor electronic 
coupling to the deeply buried heme.  An excellent example of a system highly coupled 
for electron transfer (ET) was presented by Sevrioukova et al:  they achieved rapid heme 
reduction of BM3 photochemically (2.5 x 106 s-1 and 4.6 x 105 s-1 with and without 
substrate) by covalently tethering a ruthenium diimine to an engineered cysteine (N387C) 
on the heme domain of BM3 (hBM3).3  The positioning of the Ru complex was meant to 
mimic the interaction between hBM3 and its reductase; indeed, the rapid rates suggest 
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that the complex was attached at a position that was well coupled to the heme.  It 
occurred to us that “wiring” the N387C hBM3 mutant to an electrode through the 
engineered cysteine could also yield high electron tunneling rates.  Previously, Katz 
utilized N-(1-pyrene)iodoacetamide (Py) (thiol specific) to anchor and electronically 
connect a photosynthetic reaction center to a basal plane graphite (BPG) electrode.4  
Thus, we made the hBM3 single surface cysteine mutant at position 387, attached Py to 
the cysteine, and successfully achieved rapid ET with the use of a BPG electrode.  Wiring 
the enzyme in this way creates a system where the electrode mimics the reductase, 
leaving the active site accessible to molecules in solution. 
 
Results and Discussion 
Mutant Cys387 
Protein integrity after labeling with Py was confirmed by observing the Soret 
band of the reduced heme at 448 nm in CO-saturated buffer.  Labeled protein (Py-hBM3) 
was verified by observing fluorescence of Py (~ 50% labeled).  The protein film was 
prepared by suspending a BPG electrode in a ~ 20 µM Py-hBM3 solution.  Cyclic 
voltammetry on the resulting film (Figure 3.1) revealed a couple centered at -340 mV.  
Neither unmodified enzyme nor Py alone produced a similar couple.  The observed E1/2 is 
assigned to the FeIII/II redox couple of the heme.5,6  Compared to the native enzyme in its 
resting state (six-coordinate heme, low spin) as measured by redox titration, this potential 
is shifted approximately +230 mV.7  As previously suggested, local electrostatic effects 
(e.g., solvation, surface interactions) likely contribute to the altered potential.5 
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The cathodic to anodic peak-current ratio in Figure 3.1 is approximately 1.05, 
indicating a chemically reversible system.8  A plot of the cathodic peak current versus the 
scan rate is linear, characteristic of a surface-confined species.8  This plot also indicates 
the number of electrons transferred: the slope of the line divided by the area under the 
voltammogram at any sweep rate (39 nC) is equal to nF/4RT.9  Performing this operation 
yields n = 1.2 ± 0.1, fully consistent with one-electron transfer. 
Voltammetry in CO-saturated buffer shifted E1/2 by +35 mV, as found for other 
P450 electrochemical systems (+45 mV to +80 mV).6,10,11  The E1/2 was also found to 
vary linearly with pH according to 
E1/2 = 56 mV – 58 mV/pH 
This indicates proton-coupled electron transfer.12,13 
To characterize the surface, protein films were cast onto highly oriented pyrolytic 
graphite (HOPG) and imaged using atomic force microscopy (AFM) in tapping mode.  
Figure 3.2a shows a section of HOPG (800 nm x 800 nm) soaked in a Py-hBM3 
solution, revealing a series of small islands (dark spots) ranging from 2-5 nm in height.  
Given that hBM3 is ~ 65 Å in diameter, it can be inferred that these islands represent 
protein clusters on the surface.  Figure 3.2b shows the corresponding image of HOPG 
soaked in unlabeled hBM3.  Clearly, no surface features are visible; this image is 
identical with HOPG soaked in buffer alone, and implies that only the Py-hBM3 
conjugate adsorbs to the surface.  Regarding surface coverage, Figure 3.2a suggests that 
there is sub-monolayer coverage.  Cyclic voltammetry experiments on HOPG (0.25 cm2) 
with a Py-hBM3 film (hBM3 monolayer = 1.4 x 10-12 mols) confirm this finding: 
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integrating under the cathodic peak yielded 6.2 x 10-13 mols of electroactive protein, or ~ 
44% surface coverage. 
The standard rate constant (ko, ∆Go = 0) for the BPG-Py-hBM3 system was 
evaluated using Laviron’s theory,14 yielding a value of 650 ± 50 s-1, which is the fastest 
electrode kinetics reported for any P450 system (Table 3.1 ).  ET rates for photochemical 
reduction of the FeIII heme3 were used to estimate rates at zero driving force (∆Go = 0) for 
substrate-free and substrate-bound hBM3: these were found to be 280 and 3300 s-1.*  As 
can be seen, ko from our electrochemical experiments falls within this range. 
The BPG-Py-hBM3 system is an excellent catalyst for dioxygen reduction 
(Figure 3.3).  Negative controls (Py or hBM3 on BPG only) reveal slow dioxygen 
reduction at more negative potentials.  Possible fates of dioxygen are reduction to 
peroxide (directly or through superoxide decomposition) or to water.  To determine the 
number of electrons transferred to dioxygen, Py-hBM3 films were cast onto a BPG 
rotated-disk electrode (RDE).  Using the Levich equation for an RDE,8 
iL = 0.62nFADo2/3ω½v-1/6C 
theoretical lines for the one-, two-, and four-electron reduction of dioxygen were 
generated (Figure 3.4).†  RDE experiments were conducted by performing electrolysis at 
-0.5 V and determining the limiting current for each rotation rate.  The results of these 
experiments (solid points, Figure 3.4) scatter around the theoretical line for n = 4, 
suggesting that the BPG-Py-hBM3 system converts dioxygen primarily to water.  Our 
proposal of an efficient four-electron reduction pathway is further supported by results 
                                                
* See Experimental Methods for details on the calculation. 
† The variables for air saturated water are: limiting current (iL,A), electrode area (A, cm2), diffusion 
coefficient (Do, 1.7 x 10-5 cm2/s for O2 in water), angular velocity (ω, s-1), kinematic viscosity (v, 0.01 
cm2/s for water), bulk concentration (C, 2.5 x 10-7 mol/cm3 for O2 in air saturated buffer at 25oC). 
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from an Amplex Red fluorescence assay for hydrogen peroxide, which revealed that only 
a small fraction of the current (< 17%) was used to generate the two-electron reduction 
product.  This is in stark contrast to other P450 electrochemical systems, where peroxide 
is the primary product of dioxygen reduction.10,12  Conceivably, dioxygen reduction to 
water can occur if ET is fast enough such that, after initial reaction to form a peroxy 
complex, the final two electrons arrive at the active site before peroxide dissociation.  A 
precedent for this can be found in previous work with ruthenium-modified cobalt 
porphyrins:15 π-backbonding by the ruthenium ligands increased the ET rate, creating a 
catalyst that reduced dioxygen primarily to water.  For the BPG-Py-hBM3 system, the 
estimated ko is so high that applying a potential of -0.5 V apparently leads to rapid 
reduction of dioxygen to water. 
Mutant Cys62 
In the study reported by Sevrioukova et al.,3 two single-surface-cysteine mutants 
were examined, Cys387 and Cys62.  Attaching the Ru complex to Cys62 did not result in 
observable ET.  We found this intriguing: as shown in Figure 3.5, both positions are on 
the proximal side of the heme on the protein surface.  Cys62 is spatially closer to the heme 
(15 Å), while Cys387, although farther (19 Å), provides a potential through-bond pathway 
for heme reduction.  The fact that the photochemical experiments with Cys62 resulted in 
no ET suggests that the Ru complex was not able to dock with the protein in a favorable 
orientation for ET.  However, it is possible that anchoring Cys62 with Py onto BPG would 
allow the protein to optimally position itself on the electrode surface for rapid heme 
reduction.   
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We created the single-surface-cysteine mutant Cys62, modified it with Py, and 
anchored it onto the surface of BPG.  As can be seen from the voltammogram in Figure 
3.6, this construct also appears to be electrochemically active and yields a voltammogram 
similar to Cys387.  However, although the E1/2 for both mutants is similar, the 
voltammograms do differ in their peak separation (Ep,c – Ep,a): 55 ± 1 mV for Cys387 and 
98 ± 3 mV for Cys62.  Increased peak separation for a surface bound species is indicative 
of greater resistance to charge transfer,8 implying that electronic coupling between the 
electrode and the heme in Cys62 is less efficient compared to Cys387.   
The appropriate parameter for comparing the ET is ko, which is estimated using 
Laviron’s theory at scan rates where the peak separation is greater than 200 mV.14  
However, the smaller surface coverage (39 nC for Cys387 cf. 24 nC for Cys62) made it 
difficult to record interpretable voltammograms at scan rates higher than 12 V/s for 
Cys62.  Laviron’s theory does permit an estimation of ko at scan rates where the limiting 
forms of the theoretical equations cannot be used; however, under these conditions there 
is a significant dependence of ko on the scan rate, and so comparisons between the two 
mutants must be made at the same scan rate and should only be considered as a relative 
comparison within the context of the system.  With this in mind, ko evaluated at 8 V/s for 
Cys387 and Cys62 are 197 ± 12 s-1 and 84 ± 5 s-1, respectively.  Thus, although Cys62 
appears to have slower ET kinetics compared to Cys387, clearly Cys62 can still participate 
in rapid ET with the electrode.   
Oxidative Catalysis 
To test for hydroxylation acitivity, the substrate 12-p-nitrophenylcarboxylic acid 
(12-pNCA) was used.  Hydroxylation at the carbon adjacent to the phenoxy group 
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produces a hemiacetal that rapidly decomposes to p-nitrophenol (pNP).16  The product 
pNP can be readily detected spectrophotometrically at 400 nm, or electrochemically by 
looking for oxidation of pNP to the phenoxy radical at ~ 890 mV.17   
Catalysis experiments were performed by sweeping the potential continuously at 
20 mV/s between -250 mV and -600 mV for two hours.  Experiments were performed 
this way because it was unclear at precisely what potential the reaction would be optimal;  
conceivably, performing bulk electrolysis at the wrong potential could result in ET being 
too fast or slow, leading to uncoupling.  For all reactions, both positive (Py-hBM3 films) 
and negative (BPG only) controls were performed.  Once completed, the reactions were 
immediately assayed electrochemically for pNP, after which they were concentrated ten 
times and then assayed spectrophotometrically.   
Catalysis experiments were performed with both Cys62 and Cys387.  However, 
pNP could not be definitively detected using either the electrochemical or absorption 
assays.  The inability of the Py-BM3-BPG system to support oxidative catalysis is 
probably due to improper protein folding on the electrode surface.  This supposition is 
supported by two observations.  First, there is the small shift in E1/2 (+35 mV) when 
voltammograms are recorded in CO-saturated buffer.  For comparison, the redox 
potential of the FeIII/II couple in native rabbit liver P450 in the presence of CO is shifted 
+180 mV.18  Thus, the small shift in the BM3 heme potential in the presence of CO likely 
indicates a perturbed heme environment on the electrode.  Second, once immobilized on 
the surface, the protein probably loses much of its flexibility due to aggregation.  This is 
supported by the AFM image in Figure 3.2a, which suggests that the protein adsorbs 
onto the graphite surface in clusters.  P450s are known to undergo large conformational 
3-10 
changes upon substrate binding;19,20 restricting this motion by confining the protein to the 
electrode surface could very well abolish the enzyme’s catalytic activity.   
 
Experimental Methods 
Electrode Preparation 
Pyrolytic graphite electrodes (0.07 cm2) were used for voltammetry with the basal 
plane exposed.  The electrodes were sanded to expose a fresh surface, and then they were 
sonicated briefly in water.  Next, the electrodes were polished sequentially with 0.3 µm 
and then 0.05 µm alumina slurries, followed by sonication and drying in air.  HOPG 
electrodes were cleaned by removing a few layers from the surface with adhesive tape 
prior to use. 
Mutagenesis and Protein Expression 
The single surface cysteine mutants at positions 62 and 387 were constructed as 
previously described.3  During cloning, a 6-His tag was introduced at the C-terminus of 
the protein after Thr464, followed by a stop codon.   Cloning, expression, purification, and 
quantification of the protein proceeded as previously described.21   
Protein and Electrode Modification 
 N-(1-pyrene)iodoacetamide (Py) was purchased from Molecular Probes.  A 20 
µM stock solution of the Py probe was made in DMSO.  A solution containing 50 µM 
protein in 30 mM KPi pH 7.4 buffer was partially degassed by blowing Ar over it for 20 
minutes.  Next, 15 µL of the Py solution was slowly added to the protein solution while 
being stirred.  This mixture was protected from light with aluminum foil and left stirring 
in the dark under a constant stream of argon at room temperature.  After two hours, the 
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solution was passed over a PD 10 column (Pharmacia) equilibrated with 30 mM KPi pH 
7.4 to separate the unreacted probe from the Py-hBM3 conjugate.  Electrodes were filmed 
by suspending them in 200 µL of the Py-hBM3 solution in a refrigerator (~ 10oC) 
overnight.   
 Fluorescence of the pyrene probe was used to confirm labeling of the protein, as 
described by Molecular Probes.  Emission spectra of the purified pyrene-protein 
conjugate were recorded after excitation at 340 nm.  For the assay, the protein solution 
was diluted to 2.6 µM with 30 mM KPi pH 7.4.   
 The labeling efficiency was determined using Ellman’s reagent, 5,5’-dithio-bis-
(2-nitrobenzoic acid), for quantifying free sulfhydryl groups as described by Pierce 
Biotechnology.  A purified solution of the protein-pyrene conjugate was diluted to 0.4 
µM with 50 mM KPi pH 8 to a final volume of 1 mL.  50 µL of a 4 mg/mL solution of 
Ellman’s reagent were added to the diluted protein, and the absorption spectrum was 
recorded.  The number of free cysteines was calculated using an extinction coefficient of 
14,150 M-1cm-1 at Abs412.  Based on this, the labeling efficiency was determined to be 
50%. 
Voltammetry 
A CH Instruments Electrochemical Workstation system was used for all 
electrochemistry.  Voltammetry was performed in a three compartment cell, with a frit 
and Luggin capillary separating the Pt wire auxiliary and Ag/AgCl reference, 
respectively.  The buffer solution, 50 mM KPi / 20 mM KCl / pH 7, was thoroughly 
degassed by bubbling argon through it for at least 20 minutes.  After degassing, argon 
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was continuously blown through the headspace of the cell to maintain an anaerobic 
environment. 
Rotated-Disk Electrode Experiments 
 A 0.13 cm2 pyrolytic graphite electrode with the basal plane exposed was used.  
The electrode was sanded, polished sequentially with 0.3 µm and 0.05 µm alumina 
slurries, sonicated, and dried.  Experiments were carried out in a two compartment cell, 
with the working electrode separated from the Ag/AgCl reference and Pt auxiliary 
electrodes.  The solution was approximately 30 mL of 50 mM KPi / 20 mM KCl / pH 7.  
All experiments involving oxygen reduction were carried out in air saturated buffer ([O2] 
~ 250 µM).  A Pine Instruments rotator was used to control the rotation rate, while a CH 
Instruments Electrochemical Workstation was used to apply the potential and monitor the 
current response.   
BPG-RDE experiments with Py-hBM3 films were conducted by performing bulk 
electrolysis at -0.5 V at different rotation rates.  Typically, the limiting current used to 
make the Levich plot is the steady state value observed during the reaction.  However, it 
was found that decomposition of the films occurred over the course of the experiment.  
This was illustrated both by the decay of the current response with time during the 
rotation experiment, and the reduced current response of the film after rotation compared 
to before rotation as seen by cyclic voltammetry.  Thus, the limiting current was taken to 
be the initial current after the start of electrolysis with rotation.  This was done by 
plotting the log(current) vs. time, and extrapolating the data back to t = 0 s.  Rotation 
rates above 700 rpm resulted in highly irreproducible data due to rapid film 
decomposition.   
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Hydrogen Peroxide Assay 
 Hydrogen peroxide concentrations were determined using the Amplex Red 
fluorescence assay supplied by Molecular Probes, using the 96-well procedure precisely 
as described by the company.  Based on the standard curve generated, the detection limit 
was determined to be ~ 30 nM. 
Calculation of Electron Transfer Rates 
 Rates for the photochemical system were calculated using the equation 
kET = A exp[-(∆Go + λ)/(4λkBT)] 
where λ was approximated to be 0.8 eV at 298 K.  The zero-driving force rates (∆Go = 0) 
were calculated by equating the pre-exponential factors (A) for the photochemical 
experiments with known rate (∆Go = -0.98 eV or -1.11 eV for substrate free and substrate 
bound hBM3, respectively) to the scenario with no driving force and solving for kET(∆Go 
= 0).   
 The standard rate constant (ko) for the electrochemical system was calculated 
from Laviron’s theory using the theoretical curve for α = 0.5.  The peak splitting (Ep,c – 
Ep,a) determined at 100 V/s was 130 mV.   
pNP Assays 
 A 15 mM solution of the substrate 12-pNCA was made in DMSO and dissolved 
by heating briefly to 80oC.  50 µL of the substrate solution were added to 1 mL of 5 mM 
KPi pH 8.  This solution was placed into the working compartment of a three 
compartment cell.  The working electrode (Py-hBM3 filmed or un-filmed BPG) was 
placed into the cell and the potential was cycled between -0.25 V and -0.6 V at 20 mV/s 
for two hours with slow stirring in air.  After the reaction, the working electrode was 
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replaced with a 1.5 mm diameter glassy carbon electrode that was prepared by polishing 
with 0.3 um and then 0.05 um alumina, sonicating, and drying.  Using this electrode, the 
potential was swept between 0.6 V and 1.1 V at 50 mV/s to assay for pNP produced, 
which would be indicated by an oxidation wave at 890 mV (phenoxy radical).  The 
solution was then removed and the solvent was evaporated, followed by resuspending the 
precipitated salts in 100 µL 50 mM KPi pH 8.  This solution was then analyzed using a 
spectrophotometer for absorbance at 400 nm.   
 Electrochemical determination of pNP concentrations utilized the Randles-Sevcik 
equation, Ip = (2.687 x 105)n3/2v1/2D½AC, where n is the number of electrons transferred, 
v is the scan rate (V/s), D is the diffusion coefficient (cm2/s), A is the area of the 
electrode (cm2), and C is the bulk concentration of pNP.  The diffusion coefficient of 
pNP was experimentally determined to be 2.1 x 10-6 cm2/s using the Randles-Sevcik 
equation.  Spectrophotometric determination of pNP utilized an experimentally 
determined molar absorptivity of 13700 M-1cm-1 in 50 mM KPi pH 8. 
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Table 3.1. Comparison of ko for various heme protein electrochemical systems. 
 
System ko (s-1) Ref. 
 
 
Pyrene modified heme domain BM3 on graphite 
 
650 This work 
CAM on glassy carbon coated with montmorillonite 
 
5-152 6 
Heme domain BM3 in a DDAB film 
 
221 10 
Hb in DHP-PDDA film 
 
30 22 
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Figure 3.1. Cyclic voltammogram of the Py-hBM3 conjugate on BPG (0.07 cm2) at 200 
mV/s in 50 mM KPi / 20 mM KCl / pH 7.   
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Figure 3.2. 800 nm x 800 nm AFM images of HOPG soaked in (a) Py-hBM3 and (b) 
hBM3.   
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Figure 3.3. Cyclic voltammograms at 200 mV/s of Py-hBM3 on BPG in the presence of 
increasing amounts of dioxygen: (a) 0 µM, (b) 42 µM, (c) 71 µM, (d) 94 µM.   
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Figure 3.4. Solid lines: Levich plots derived for the one-, two-, and four-electron 
reductions of dioxygen.  The points represent the limiting current at 400, 600, and 700 
rpm for Py-hBM3 films on BPG-RDE in the presence of dioxygen (250 µM). 
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Figure 3.5.  The 380-400 peptide loop is shown, as are the positions of residues 62 and 
387 relative to the heme.   
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Figure 3.6. Cyclic voltammogram at 200 mV/s of the Cys62 mutant modified with Py and 
filmed onto BPG (0.07 cm2) in 50 mM KPi / 20 mM KCl / pH 7.   
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Chapter 4 
 
Electrochemistry of Cytochrome P450 BM3 in Sodium Dodecyl Sulfate Films 
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Abstract 
 Direct electrochemistry of the cytochrome P450 BM3 heme domain was achieved 
by confining the protein within SDS films on the surface of basal plane graphite 
electrodes.  Cyclic voltammetry revealed a reversible couple due to FeIII/II centered at  
-330 mV vs. Ag/AgCl at pH 7.4.  Laviron’s theory was used to estimate a standard rate 
constant of 40 s-1.  Voltammograms in the presence of dioxygen resulted in catalytic 
waves at the onset of FeIII reduction.  Electrolyses performed in the presence of dioxygen 
and substrates did not result in any products, suggesting that the protein is not capable of 
catalyzing substrate oxidation within the SDS film.   
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Abbreviations: hBM3, heme domain cytochrome P450 BM3; ET, electron transfer; SDS, 
sodium dodecyl sulfate; BPG, basal plane graphite; DDAB, 
didodecyldimethylammonium bromide. 
 
Introduction 
The ability of cytochromes P450 to perform challenging oxidation reactions under 
physiological conditions makes them attractive targets for in vitro applications.  As 
discussed in Chapter 1, capturing the activity of cytochrome P450 BM3 in vitro would 
be greatly facilitated if reductants other than NADPH could be found.  Following this 
theme, Chapter 2 described the application of dicarboxycobaltocene as a recyclable 
electrochemical mediator for BM3 biocatalysis.   
In addition to replacing NADPH, eliminating the BM3 reductase domain would 
further aid in vitro applications by 1) dispensing with the relatively unstable flavin 
cofactors,1 2) avoiding enzyme inactivation by over-reducing the flavins,2 and 3) 
eliminating uncoupling of electron transfer (ET) through cleavage of the reductase-heme 
domain linkage.3  Direct reduction of the BM3 heme domain (hBM3) with an electrode is 
perhaps the simplest method of supplying the necessary reducing equivalents for 
catalysis.  In pursuit of this, Chapter 3 described a novel methodology for achieving 
direct hBM3 electrochemistry by “wiring” the protein to the electrode surface.  However, 
substrate oxidation was not observed. 
Some of the most successful bioelectrochemical systems employ the use of 
protein films on conductive supports to achieve efficient electronic coupling between the 
electrode and the enzyme.  In particular, Rusling has pioneered the use of surfactant films 
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on carbon surfaces for direct electrochemistry of heme proteins.4  The surfactant is 
deposited onto the electrode, resulting in the formation of bilayers and micelles into 
which the protein incorporates.  The end result is a system that supports rapid and 
reversible ET between the electrode and the enzyme; this is in sharp contrast to the slow 
and quasi-reversible electrochemistry of heme proteins in solution.5  In addition to 
enhancing ET, the surfactant film also confers stability to the enzyme-electrode system.  
It has been shown that even after prolonged storage, the enzyme can retain most of its 
electrochemical activity (e.g., up to 90% active after one month of storage at 4oC).4  
These advantages have led to many studies exploiting this technique, and subsequent 
comprehensive reviews on thin film electrochemistry.6,7   
Utilizing the surfactant film methodology, we attempted to create a catalytic 
system with hBM3 using sodium dodecyl sulfate (SDS) films on the surface of basal 
plane graphite electrodes (BPG).  Notably, SDS films have been successfully used for 
myoglobin on graphite electrodes:8 the FeIII/II couple was observed at -232 mV (vs. 
Ag/AgCl), and ET was rapid and reversible.  Thus, based on this prior work, we 
attempted to develop a similar system for catalysis with hBM3.   
 
Results and Discussion 
Protein films were cast onto BPG by applying a solution of hBM3, surfactant, and 
buffer to the surface, followed by slow evaporation of the water under high humidity.  A 
representative voltammogram of hBM3 in SDS is shown in Figure 4.1.  Negative 
controls (no enzyme, no film, or graphite alone) resulted in no observable waves.  E1/2 
was measured to be -330 mV (pH 7.4, vs. Ag/AgCl), consistent with the FeIII/II redox 
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couple of the heme.4  Compared to hBM3 in solution (six coordinate heme, low spin), 
this potential is shifted +237 mV.9  Typically, potential shifts on electrode surfaces are 
attributed to effects from the local electrostatic environment (buffer, surfactant, etc.).10  In 
this instance, the potential shift is likely a consequence of local electrostatic effects and 
perturbation of the heme spin state resulting from SDS binding in the active site.  SDS is 
a substrate for BM3 (ω-1 and ω-2 hydroxylation) and causes a low- to high-spin shift of 
the FeIII heme when bound in the active site, resulting in a higher heme potential.  Since a 
large excess of SDS is present during the filming process, an SDS molecule most 
certainly binds in the active site and is thus partially responsible for the altered heme 
potential observed during voltammetry.   
Previous work with P450 confined in didodecyldimethylammonium bromide 
(DDAB) films on graphite revealed that the FeII/I redox couple is also accessible.11  
However, attempts to access the hBM3 FeII/I couple in SDS on BPG by scanning to -1.5 
V resulted in no observable signals.  In addition, scanning in the region of the FeIII/II 
couple after scanning out to -1.5 V resulted in complete loss of the protein response.  
Most likely, polarizing the electrode to such a negative potential causes desorption of the 
negatively charged SDS molecules, with subsequent loss of the protein signal.  A related 
phenomenon has been observed for DDAB films on graphite: polarizing the electrode by 
applying a positive potential causes a phase transition in this positively charged surfactant 
to a more liquid-like state.12  Given the high solubility and relatively high critical micelle 
concentration of SDS, a similar phase transition would likely cause this surfactant to 
desorb from the graphite surface. 
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Up to 10 V/s, the peak current was found to be linear with scan rate, indicating a 
surface confined system.13  Analysis of Figure 4.1 revealed that the cathodic to anodic 
peak current ratio (I p,c / I p,a) was 0.9, which demonstrates electrochemical reversibility: 
all of the redox active sites that are reduced during the cathodic sweep are re-oxidized on 
the reverse scan.13  Regarding surface coverage, the number of moles of electroactive 
protein reduced during the cathodic sweep can be determined by integrating under the 
peak in Figure 4.1.  When this is done, a value of 3 µC is found, which results in a 
surface coverage (ΓP450) of 2 x 10-10 mol/cm2 and corresponds to approximately 33% of 
the total protein deposited during filming.  Loading more protein onto the surface during 
filming did not increase the amount that was electroactive.  The calculated surface 
coverage is comparable to other systems (cf. 1 x 10-10 mol/cm2 for hemoglobin14 and  
7 x 10-10 mol/cm2 for P450 CAM24).   
 Laviron’s theory was used to estimate the standard rate constant (ko, ∆Go = 0).15  
ko evaluated at 10 V/s was determined to be 40 s-1.  For comparison, ko for hBM3 in 
DDAB films on pyrolytic graphite is 221 s-1.16  Thus, although ET for hBM3 in SDS is 
slow compared to hBM3 in DDAB, it is still much faster than direct electrochemistry of 
P450 in solution (~ 0.01 s-1).17   
Catalytic activity was first assessed by observing the response of the system to 
dioxygen.  Figure 4.2 displays voltammograms of hBM3 in SDS on BPG in the presence 
of increasing amounts of dioxygen.  Figure 4.2 contains three important observations:  
1) the voltammograms become increasingly less reversible as more dioxygen is added, 
indicating oxidation of the reduced heme by dioxygen; 2) the cathodic peak potential 
shifts positive with increasing amounts of dioxygen in solution, illustrating the known 
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potential shift that accompanies dioxygen binding to the heme;18 3) the cathodic peak 
current increases with increasing amounts of dioxygen, indicating catalytic reduction of 
dioxygen.  Voltammograms in the absence of protein result in slow dioxygen reduction 
occurring at more negative potentials.   
Next, the system was assayed for its ability to support catalytic substrate 
oxidation.  For these reactions, films were prepared on larger pieces of graphite or carbon 
cloth (see Experimental Methods).  Electrolysis reactions were conducted at -0.6 V (vs. 
Ag/AgCl) in a stirred cell in air.  Several substrates were tried, including lauric acid, 
styrene, and oxidation of the SDS film itself.  However, no oxidized products were 
observed using wild type hBM3.   
Previous work with P450 CAM suggested that catalysis within films on electrode 
surfaces occurs through the peroxide shunt: hydrogen peroxide formed by P450-catalyzed 
reduction of dioxygen is used to support substrate oxidation.19  This was confirmed by 
performing control reactions with catalase, which inhibited product formation.  To 
determine if hBM3 is in fact competent for substrate oxidation within the SDS film, 
catalysis experiments were conducted using hBM3 mutant 5H6, which has enhanced 
catalytic activity utilizing the peroxide shunt pathway.20  However, performing 
electrolysis experiments with 5H6 resulted in no substrate oxidation.  The ability of the 
protein to reduce dioxygen, coupled with an inability to perform substrate oxidation, 
suggests: 1) the enzyme is not in a conformation that allows substrates to bind; 2) the 
substrates have a higher affinity for the film, and therefore do not partition into the 
protein active site; 3) polarizing the electrode negatively for extended periods of time 
causes film desorption.  Evidence for (1) and (2) comes from anaerobic voltammograms 
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in the presence of substrate: the potential of the FeIII/II couple is insensitive to the 
presence of substrates, which is in contrast to the known potential shifts that occur upon 
substrate binding.  Evidence to support (3) comes from voltammetry after electrolysis, 
which reveals that the FeIII/II couple is no longer present.  Thus, the inability of hBM3 to 
perform substrate oxidation in SDS films is likely due in some part to all of these factors. 
 
Experimental Methods 
Protein Expression and Purification 
 Expression and purification of wild type and mutant BM3 heme domains 
proceeded as previously described.21 
Electrode Preparation and Voltammetry with hBM3-SDS Films 
Electrodes were made using the basal plane of pyrolitic graphite (Union Carbide) 
(0.2 cm2).  The surfaces were prepared by abrasion with 600-grit sandpaper, followed by 
brief sonication in ddH2O and drying with a heat gun.  Protein films were applied by 
placing 20 µL of a solution containing 6 µM hBM3, 15 mM SDS, and 8 mM KPi pH 7.4 
onto the electrode surface.  The electrodes were covered under water-saturated air for 6 
hours, followed by uncovering and drying in air overnight.  Prior to voltammetry, the 
films were thoroughly dried under vacuum for 1 hour. 
 A CH Instruments Electrochemical Workstation was used for the reactions.  
Voltammetry experiments were performed in a three-compartment cell, using a platinum 
wire auxiliary and a Ag/AgCl reference (BAS).  The buffer, 30 mM KPi  / 130 mM NaCl 
/ pH 7.4, was thoroughly degassed by evacuating and backfilling with argon multiple 
times.  All experiments were performed under argon unless otherwise stated. 
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Electrode Preparation for Bulk Electrolysis with hBM3-SDS Films 
 Carbon cloth electrodes (ElectroChem, Inc.) were cleaned by soaking in 
concentrated nitric acid for 1 hr, followed by repeated rinsing with ddH2O and final 
drying with a heat gun.  Films were cast by soaking the electrode in a solution of 10 mM 
SDS, 5 µM hBM3, and 6 mM KPi pH 7.4 for 5 hrs, followed by drying in air overnight.   
Pyrolytic graphite for electrolysis was obtained from GE Advanced Ceramics.  
The surface was prepared by abrading with 600-grit sandpaper, followed by brief 
sonication in ddH2O and drying with a heat gun.  Protein films were applied by placing 
250 µL of a solution containing 6 µM hBM3, 15 mM SDS, and 8 mM KPi pH 7.4 onto 
the electrode surface.  The electrodes were covered under water-saturated air overnight, 
followed by uncovering and drying in air overnight.   
Electrolysis Protocols and Activity Assays 
Electrolysis reactions were performed in a two-compartment cell separated by a 
glass frit, with the working and reference Ag/AgCl electrodes in one compartment and 
the Pt auxiliary in the second compartment.  The potential was set to -0.6 V, and the cell 
was stirred in air.  The reaction solution typically consisted of 1-5 mM of substrate (lauric 
acid, styrene) in 30 mM KPi / 130 mM KCl / pH 7.4 buffer, in a final volume of 10 mL.  
The reaction was allowed to proceed for 1 hr, after which it was extracted and analyzed 
by GC/MS.  GC/MS protocols for lauric acid and SDS were performed as described21 
(details also in Chapter 2).   
For styrene reactions, 5 µL of a 5 mM solution of 1-hexanol in methanol (internal 
standard) were added to the reaction solution after electrolysis, followed by extraction 
with 400 µL of CHCl3.  The extract was then analyzed by GC/MS using an Innowax 
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column.  Styrene, styrene oxide, and benzaldehyde were quantified using a calibration 
curve constructed from standards, and relating the area of these standards to that of the 
internal standard.   
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Figure 4.1. Cyclic voltammogram of hBM3 in SDS on BPG (0.2 cm2) at 200 mV/s in 30 
mM KPi  / 130 mM NaCl / pH 7.4.  
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Figure 4.2. Cyclic voltammograms of hBM3 in SDS on BPG in the presence of 
increasing amounts of dioxygen: (a) 0 µM, (b) 42 µM, (c) 83 µM.   
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Chapter 5 
 
Voltammetry of Wild Type and Mutant Cytochrome P450 BM3 in DDAPSS 
Surfactant Films* 
 
 
 
 
 
 
 
*Reproduced in part with permission from Inorganic Chemistry, in press.  Unpublished 
work copyright 2005 American Chemical Society. 
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Abstract 
Voltammetry of mutant cytrochrome P450 BM3 (1-12G) in DDAPSS films on 
graphite revealed FeIII/II (-202 mV vs. Ag/AgCl) and FeII/I (-1082 mV) redox couples of 
the heme.  The FeII species was capable of catalyzing dioxygen reduction, while 
reductive dechlorination of TCA was catalyzed by FeI.  Performing voltammetry on the 
wild type (WT) enzyme revealed that WT and 1-12G display distinct redox properties.  
Absorption spectra in solution showed the FeIII Soret at 418 nm for WT, and a split Soret 
for 1-12G at 390 and 418 nm.  Voltammetry of the proteins within DDAPSS films on the 
surface of carbon electrodes revealed near identical FeIII/II potentials (~ -200 mV vs. 
Ag/AgCl), but significant differences in ko (250 vs. 30 s-1) and FeIII/II – CO potentials  
(-140 mV vs. -115 mV) for WT vs. 1-12G.  Catalytic reduction of dioxygen by the 
proteins on rotated-disk electrodes was analyzed using Levich and Koutecky-Levich 
treatments.  The data reveal that 1-12G displays n and kobs values that are 1.7 and 0.07 
times that of WT, suggesting that the two proteins differ strikingly in their reaction with 
dioxygen. 
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Abbreviations: P450, cytochrome P450; WT, wild type heme domain cytochrome P450 
BM3; 1-12G, cytochrome P450 BM3 heme domain mutant 1-12G; BPG, basal plane 
graphite electrode; DDAB, didodecyldimethylammonium bromide; NaPSS, sodium 
polystyrenesulfonate; DDAPSS, didodecyldimethylammonium polystyrenesulfonate; 
RDE, rotated-disk electrode; ET, electron transfer; CYP119, cytochrome P450 from 
Sulfolobus solfataricus; CAM, cytochrome P450 from Pseudomonas putida; TCA, 
trichloroacetic acid. 
 
Introduction 
Protein-surfactant film voltammetry is a proven technique for achieving good 
electronic coupling between electrodes and redox enzymes.1  This methodology has been 
particularly useful in exploring the redox properties of cytochromes P450.2-5  In addition 
to supporting rapid and reversible electron transfer (ET), these systems can also catalyze 
a limited number of turnovers (e.g., 7.2 turnovers per hour for cytochrome P450 from 
Pseudomonas putida (CAM) with styrene as substrate6).   
Chapter 4 described the electrochemistry of wild type heme domain cytochrome 
P450 BM3 (WT) in a sodium dodecyl sulfate (SDS) film on the surface of a basal plane 
graphite electrode (BPG).  Although the system displayed good electronic coupling, 
catalytic substrate monooxygenation was not observed.  Several explanations were 
suggested for this lack of activity including film desorption, protein misfolding, and 
hindered substrate access (by SDS occupying the substrate access channel, or substrates 
preferentially partitioning into the film). 
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To combat the problems associated with the WT-SDS system, we decided to 
explore the voltammetry of BM3 heme domain mutant 1-12G (1-12G) in 
didodecyldimethylammonium polystyrenesulfonate (DDAPSS) films.  1-12G contains 15 
amino acid mutations that distinguish it from WT; these mutations are collectively 
responsible for 1-12G’s unique catalytic properties, which include the ability to regio- 
and stereoselectively hydroxylate linear hydrocarbons (e.g., formation of S-2-octanol at 
40% ee), and oxidize small gaseous alkanes (e.g., propane).7  We hoped that the altered 
substrate specificity of 1-12G (cf. WT) would allow us to find molecules that could freely 
diffuse through the surfactant film into the protein active site for protein-catalyzed 
oxidation.   
Regarding the surfactant, heme proteins within DDAPSS films have been shown 
to retain their spectroscopic properties (cf. in solution), and are active towards dioxygen 
reduction and reductive dehalogenation.8,9  Furthermore, DDAPSS films are very stable 
(cf. SDS), owing to low water-solubility and superior strength against mechanical 
stresses.8  Finally, DDAPSS is not a substrate for BM3: absorption spectroscopy reveals 
that the surfactant does not cause a low- to high-spin shift in the heme FeIII Soret, and 
NADPH is not consumed in solutions containing the holo enzyme and this surfactant. 
Notably, previous work described the redox properties of WT in 
didodecyldimethylammonium bromide (DDAB) films.4  The FeIII/II redox potential, 
standard rate constant (ko), and dioxygen reactivity of the system were reported.  This 
prior study serves as a convenient point of reference for the present investigation of WT 
and 1-12G in DDAPSS.   
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Voltammetry of 1-12G in DDAPSS 
Protein films were formed on BPG by adding 1-12G, DDAB, and NaPSS directly 
to the electrode surface, followed by drying in air.  A representative voltammogram at pH 
7 for 1-12G in DDAPSS is shown in Figure 5.1.  We have assigned the two redox 
processes to the heme FeIII/II (-202 mV vs. Ag/AgCl) and FeII/I redox couples (-1082 mV), 
consistent with other studies.8,10  These assignments are supported by performing 
voltammetry in the presence of carbon monoxide: with CO present, the FeIII/II couple 
shifts approximately +87 mV (consistent with other studies3,4) while the FeII/I couple is no 
longer observed (presumably beyond the solvent window).  Notably, the FeIII/II redox 
potential in the surfactant film is 370 mV more positive than the WT enzyme in 
solution.11  As previously suggested, local electrostatic effects probably contribute to the 
altered potentials on the electrode surface.12  In particular, the hydrophobic film likely 
leads to partial dehydration of the protein active site, which would cause a significant 
positive shift in the observed heme potential.13   
 
Catalytic Activity of 1-12G in DDAPSS 
Substrate Oxidation 
Voltammograms in the presence of dioxygen resulted in large catalytic currents at 
the onset of FeIII reduction (Figure 5.2).  This catalytic activity encouraged us to try a 
series of substrates with the system in the hope of observing catalytic substrate oxidation.  
Catalytic reactions were conducted in two ways: 1) by performing electrolysis at various 
potentials (both positive and negative of the FeIII/II E1/2); 2) by performing cyclic 
voltammetry at various scan rates for multiple cycles in a region that included the FeIII/II 
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redox couple.  Several substrates were tried, including medium chain (C6 – C10) alkanes 
and styrene.  Unfortunately, no oxidation products were observed. 
Reductive Dehalogenation 
The ability of 1-12G in DDAPSS to catalytically reduce dioxygen suggested that 
the system may be capable of performing simple reduction reactions.  Thus, we assessed 
the ability of 1-12G in DDAPSS to reductively dechlorinate trichloroacetic acid (TCA).  
Reductive dehalogenation is a known P450-catalyzed reaction: previous work 
demonstrated TCA dechlorination catalyzed by the FeII heme in CAM within DDAB on 
graphite,3 and FeI-catalyzed dechlorination of carbon tetrachloride by P450 from 
Sulfolobus solfataricus (CYP119) in DDAPSS on BPG.9  Regarding practical 
applications, bioelectrochemical systems that catalyze dehalogenation reactions have 
been investigated with much interest for use in bioremediation.9,14   
Figure 5.3 overlays voltammograms of BPG with TCA (a), BPG with 1-12G in 
DDAPSS (b), and BPG with 1-12G in DDAPSS in the presence of TCA (c).  The large 
catalytic current in Figure 5.3c indicates protein-mediated dechlorination catalyzed by 
FeI.  This was confirmed by GC-ECD, which revealed that the mono-dechlorinated 
product (dichloroacetic acid) is only produced in reactions that contain protein.  This 
result is in accord with CYP119-mediated dechlorination of CCl4 in DDAPSS; however, 
this is in stark contrast to CAM in DDAB, which showed CAM-mediated dechlorination 
of TCA catalyzed by FeII.  Since the FeIII/II redox potentials are similar for the three 
proteins (-202 mV for 1-12G in DDAPSS, -213 mV for CYP119 in DDAPSS,9 -191 mV 
for CAM in DDAB3) the differences in catalysis cannot be attributed to different 
potencies of the FeII hemes.  The commonality for the 1-12G and CYP119 systems is the 
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DDAPSS film.  However, the differential effect of DDAB compared to DDAPSS on the 
dehalogenation activity of the FeII heme in P450 is not obvious. 
 
Comparative Voltammetry of WT and 1-12G 
As mentioned above, the 15 mutations that distinguish 1-12G from WT are 
responsible for 1-12G’s unique catalytic properties.  Conceivably, these differences in 
catalysis may be due in part to differences in redox properties.  Previous work with WT 
has shown that single point mutations can significantly perturb the heme’s redox and 
catalytic properties.15  We suspected that the 15 mutations in 1-12G would have a similar 
effect: indeed, one of the distinguishing features of 1-12G is that, as isolated (heme 
domain, substrate free), the heme is mixed-spin (absorbance at 390 and 418 nm).  This is 
in stark contrast to WT (Figure 5.4), which shows the characteristic low spin absorption 
spectrum of the hydrated six-coordinate heme (λmax = 418 nm).   
The surfactant film methodology provides a simple and sensitive way of probing 
heme protein redox chemistry.  Thus, we decided to use the DDAPSS film system to 
explore and compare the redox chemistry of WT and 1-12G.  Performing voltammetry on 
the two proteins in DDAPSS films revealed that the two proteins give similar 
voltammograms with nearly identical half-wave potentials (Table 5.1).  A representative 
voltammogram of the FeIII/II couple at pH 7 for 1-12G in DDAPSS is shown in Figure 
5.5.  Notably, the half-wave potential of the FeIII/II couple in Figure 5.5 is in accord with 
WT in DDAB (cf. -250 mV vs. SCE).4   
For both proteins, the peak currents were linear with scan rate (surface bound) up 
to 14 V/s, after which they became linear with the square root of the scan rate 
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(diffusive).16  This is characteristic of thin film electrochemistry,17 indicative of finite 
diffusion of the protein within the film.  Thus, up to 14 V/s, the systems were treated as 
surface-confined.  Within this diffusionless regime, the ratios of the total charge under 
the cathodic and anodic peaks (Qp,c / Qp,a) approach unity for both proteins, indicating 
chemically reversible systems.16   
Voltammetry in the presence of carbon monoxide revealed a 25 mV difference in 
the FeIII/II potentials of WT and 1-12G (Table 5.1).  Approximately, this indicates a four-
fold difference in FeIII/II – CO binding affinities between WT and 1-12G in the DDAPSS 
film, and provides further evidence that the two proteins have different heme 
environments. 
Figure 5.6 plots the peak potentials vs. the log of the scan rate for both proteins.  
Despite nearly identical FeIII/II potentials, Figure 5.6 demonstrates that the two proteins 
differ significantly in their electron transfer (ET) properties.  Within the diffusionless 
regime (Figure 5.6, vertical line), the theory of Laviron can be used to estimate the 
standard rate constant ko (∆Go = 0).18  Assuming a transfer coefficient (α) of 0.5, ko 
evaluated at 10 V/s was 250 and 30 s-1 for WT and 1-12G, respectively (notably, ko for 
WT in DDAB4 is 221 s-1).   
Voltammograms of the two proteins in the presence of dioxygen resulted in 
catalytic currents at the onset of FeIII reduction.  The stability of DDAPSS films to 
mechanical stress8 permitted the use of a rotating-disk electrode (RDE) to investigate the 
dioxygen reaction.  The diffusion-convection-limited current at an RDE depends on the 
angular rotational velocity (ω, s-1), the number of electrons transferred (n), and the bulk 
concentration of substrate (O2 in this case) according to the Levich equation:19,20 
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iL = 0.62 nFAD2/3 [O2] ν-1/6 ω1/2 
RDE experiments were carried out at room temperature (20oC) in air-saturated buffer on 
both WT and 1-12G by performing electrolysis at -0.5 V (vs. Ag/AgCl) and measuring 
the limiting current for each rotation rate.  These data points are plotted in Figure 5.7 
(points), along with theoretical lines for two- and four-electron reduction of dioxygen 
(solid lines).   
For both proteins, the limiting currents in Figure 5.7 appear to level off at high 
rotation rates.  This indicates that dioxygen reduction is limited by a chemical step 
preceding the electrode reaction.  The Koutecky-Levich treatment was used to analyze 
the kinetics:21 plots of iL-1 vs. ω−1/2 were linear for both proteins, with slopes yielding n = 
2.7 for WT and n = 4.7 for 1-12G (insets, Figure 5.7).  The intercepts of the Koutecky-
Levich plots were used to calculate the kinetic currents (ikin) that limit the electrode 
reaction.  These currents vary linearly with protein concentration and are given by22 
ikin = nFA [O2] ΓP450 kobs 
(where ΓP450 is the surface concentration of protein and kobs is the second-order rate 
constant that governs the current-limiting reaction).  WT and 1-12G gave respective 
values for kobs of 1.4 x 106 M-1s-1 and 1 x 105 M-1s-1, a 14-fold difference in reaction rate.  
The calculated values for n and kobs were used to generate Levich plots for WT and 1-
12G (Figure 5.7, broken lines).   
Chemical fates of dioxygen reduction are one-, two-, and four-electron transfer 
forming superoxide, peroxide, and water.  Our calculated values for n are probably over-
estimated: within the hydrophobic film, dioxygen is likely more concentrated compared 
to in solution.23  With this in mind, it appears that WT reduces dioxygen primarily by two 
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electrons to peroxide (as seen before for WT and BM3 point mutants4,24), whereas 1-12G 
apparently reduces dioxygen by an additional two electrons.  P450-catalyzed four-
electron reduction of dioxygen has been previously observed,25,26 and is consistent with 
the canonical P450 mechanism that results in water formation by reducing compound I 
with two electrons (“oxidase” activity).27  Dioxygen reduction by 1-12G is also 
significantly slower (kobs) compared to WT, as evident from the prominent plateau at 
higher rotation rates for 1-12G where the rate of substrate delivery exceeds that of 
catalysis.   
Results from our electroanalytical treatment can be correlated with the 
biochemistry of the proteins.  First, there is the ten-fold difference in heterogeneous ET 
rate constants (ko).  Indeed, preliminary stopped-flow experiments using holo proteins 
and NADPH as the reductant revealed that heme reduction in WT occurred 
approximately five-fold faster.28  In addition, substrate turnover rates for WT29 are 
generally faster (up to ten-fold) than for 1-12G;7  since ET is known to be the rate 
limiting step, then the relative ko and kobs values are also consistent with the catalytic 
oxidation rates.  Second, there is the striking observation that under similar conditions 1-
12G appears capable of reducing dioxygen by four electrons.  This difference can be 
reconciled if the iron-peroxy species is longer-lived in 1-12G.  For WT, peroxide 
apparently dissociates before subsequent conversion to compound I.  However, the 
slower rate of ET in 1-12G, coupled with the observation of catalytic currents 
corresponding to four-electron transfer to dioxygen, argues for an iron-peroxy complex 
that is longer-lived in 1-12G relative to WT.  This could potentially explain the high 
degree of stereo- and regioselectivity that 1-12G displays: a longer-lived iron-peroxy 
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species allows substrates more time to adopt their lowest-energy conformation within the 
active site and orient a specific C-H bond for subsequent hydroxylation.  This argument 
is in accord with that previously postulated for 1-12G,7 which reasoned that the mutations 
(especially A328V and A82L in the active site) kept the substrate in a more fixed 
orientation, allowing specific products to be generated. 
 
Experimental Methods 
Protein Expression and Purification 
 Expression, purification and quantification of the heme domains of wild type 
BM3 and mutant 1-12G proceeded as previously described.30 
Electrode Preparation and Voltammetry 
Electrodes for voltammetry (0.07 cm2) were made using the basal plane of 
pyrolytic graphite.  The surfaces were prepared by sanding briefly with 600-grit 
sandpaper, followed by polishing with 0.3 and 0.05 µm alumina slurries.  The electrodes 
were then sonicated and dried in air.  Protein films were applied by placing 5 µL of 105 
µM 1-12G or 21 µM WT in 30 mM KPi pH 7.4, 5 µL 10 mM DDAB in water, and 5 µL 
10 mM NaPSS in 30 mM KPi pH 7.4 to the electrode surface.  The electrodes were 
covered under water-saturated air overnight, followed by uncovering and drying in air 
overnight.   
 A CH Instruments Electrochemical Workstation system was used for the 
reactions.  Voltammetry experiments were performed in a three-compartment cell, using 
a platinum wire auxiliary and an Ag/AgCl reference (BAS).  All experiments were 
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performed under argon in thoroughly degassed buffer (50 mM KPi / 20 mM KCl / pH 7) 
unless otherwise stated. 
Activity Assays with 1-12G 
 Electrolysis reactions were conducted with protein films on pyrolytic graphite 
plates (2 cm x 1 cm).  The plates were sanded, sonicated, and dried in air.  Protein films 
were applied by placing 7 µL of 105 µM 1-12G in 30 mM KPi pH 7.4, 7 µL 10 mM 
DDAB in water, and 7 µL 10 mM NaPSS in 30 mM KPi pH 7.4.  The electrodes were 
covered under water-saturated air overnight, followed by uncovering and drying in air 
overnight.  Electrolyses were conducted in a three-neck flask: working and counter (Pt 
gauze) electrodes were placed in solution, while the Ag/AgCl reference was housed in a 
Luggin capillary.  The flask contained 6 mL of buffer (50 mM KPi / 20 mM KCl / pH 7), 
and typically 1-5 mM of substrate. 
Assays for hydroxylated alkanes were conducted as previously described.7  
Styrene assays were conducted as described in Chapter 4.   
Electrolyses involving TCA were performed anaerobically at -1 V (vs. Ag/AgCl) 
for 15 minutes with rapid stirring.  Dechlorination products were analyzed by first 
acidifying the electrolyzed solution to pH ~ 1, followed by extraction with 0.5 mL of 
ethyl acetate.  The extract was analyzed using GC with an electron capture detector 
(ECD).   
Rotated-Disk Electrode Experiments 
0.5 cm2 glassy carbon electrodes were used.  The electrodes were polished 
sequentially with 0.3 and 0.05 µm alumina slurries, sonicated, and dried.  Experiments 
were carried out in a two-compartment cell, with the working electrode separated from 
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the Ag/AgCl reference and Pt auxiliary electrodes.  The solution was approximately 30 
mL of 50 mM KPi / 20 mM KCl / pH 7.  All experiments involving dioxygen reduction 
were carried out in air saturated buffer ([O2] approximately 290 µM at 20oC).  Protein 
surface concentrations on the RDEs were 1.5 x 10-11 and 3.3 x 10-11 mol/cm2 for WT and 
1-12G.  A Pine Instruments rotator was used to control the rotation rate, while a CH 
Instruments Electrochemical Workstation was used to apply the potential and monitor the 
current response.  Protein-DDAPSS films were found to be stable up to 1500 rpm. 
RDE experiments were conducted by performing electrolyses at -0.5 V (vs. 
Ag/AgCl) at different rotation rates.  Typically, the limiting current used to make the 
Levich and Koutecky-Levich plots is the steady state value observed during the reaction.  
However, it was found that degradation of the protein signal occurred over the course of 
the experiment (probably through peroxide damage).  This was illustrated both by the 
decay of the current response with time during the rotation experiment, and the reduced 
current response of the film after rotation compared to before rotation as seen by cyclic 
voltammetry.  Thus, the limiting current was taken to be the initial current after the start 
of electrolysis with rotation.  This was done by plotting the log(current) vs. time, and 
extrapolating the data back to t = 0 s. 
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Table 5.1.  Electrochemical parameters determined for WT and 1-12G in DDAPSS on 
BPG. 
 
 WT 1-12G 
 
E1/2 (FeIII/II) 
 
-195 mV -202 mV 
E1/2 (FeIII/II - CO) 
 
-140 mV -115 mV 
ko 
 
250 s-1 30 s-1 
kobs 
 
1.4 x 106 M-1s-1 1 x 105 M-1 s-1 
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Figure 5.1.  Cyclic voltammogram of mutant 1-12G in DDAPSS on BPG at 200 mV/s in 
50 mM KPi / 20 mM KCl / pH 7.  
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Figure 5.2.  Cyclic voltammograms of 1-12G in DDAPSS on BPG in the presence of 
increasing amounts of dioxygen.   
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Figure 5.3.  Cyclic voltammograms at 200 mV/s with: a) 1-12G in DDAPSS on BPG, b) 
1-12G in DDAPSS on BPG with TCA, c) DDAPSS on BPG with TCA. 
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Figure 5.4.  Absorption spectra of WT and 1-12G P450 BM3 in the absence of substrate.   
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Figure 5.5.  Cyclic voltammogram of mutant 1-12G in DDAPSS on BPG at 200 mV/s in 
50 mM KPi / 20 mM KCl / pH 7.  
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Figure 5.6.  Cathodic and anodic peak potentials vs. log of the scan rate for WT and 1-
12G are shown.  The vertical line represents the transition from surface-bound to 
diffusive behavior.   
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Figure 5.7.  Levich plots are shown for a) 1-12G and b) WT.  The individual points, solid 
lines, and broken lines represent the experimental data, the theoretical lines, and the lines 
derived from the fit of the experimental data, respectively.  The insets are the 
corresponding Koutecky-Levich plots, from which n and kobs were derived.  The [O2] 
used to generate the lines, 2.9 x 10-7 mol/cm3, is that of air-saturated buffer at 20oC. 
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Chapter 6 
 
Electrochemical Generation of a High-Valent State of Cytochrome P450 
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Abstract 
 Cyclic voltammetry performed at rapid scan rates on cytochrome P450 CAM in 
DDAB films on graphite electrodes revealed a couple (E) at 831 mV (vs. Ag/AgCl).  E 
was not observed at scan rates less than 30 V/s at room temperature, suggesting that the 
oxidized species is unstable. The lifetime of E could be prolonged at 4oC, which allowed 
reversible access to E at scan rates as low as 1 V/s.  E was found to be sensitive to 
imidazole in solution and to variations in pH, suggesting that the redox reaction is 
occurring at the metal center (i.e., FeIV/III) rather than at the porphyrin macrocycle.  
Electrolysis reactions with different P450 substrates revealed that the electrochemically 
generated high-valent species is only capable of performing S-oxidation, converting 
thioanisole to methyl phenyl sulfoxide.   
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Abbreviations: CV, cyclic voltammetry; ET, electron transfer; CAM, cytochrome P450 
from Pseudomonas putida. 
 
Introduction 
Heme-thiolate proteins (cytochromes P450, nitric oxide synthase, 
chloroperoxidase) perform essential functions in biology.  The hallmark reaction 
catalyzed by these enzymes is substrate oxidation, converting R-H to R-OH.  Thiol 
ligation to the heme iron is postulated to be the critical factor that modulates the heme 
redox properties to activate dioxygen for substrate oxidation:1,2 two electrons are 
delivered by native reductase proteins to reduce dioxygen, forming water and a high-
valent ferryl species (formally oxidized by two electrons cf. FeIII heme) capable of 
performing oxygen atom transfer.  This ability for oxidative catalysis has led to great 
interest in capturing heme-thiolate oxygenase activity in vitro for both medical and 
industrial applications.3,4 
Central to the catalytic cycle of heme-thiolate proteins is electron transfer (ET), 
leading to several investigations characterizing ET reactions in these enzymes.5-8  In 
particular, protein-surfactant film voltammetry has developed into a routine method for 
achieving direct ET with heme proteins.9  Using this technique, several studies have 
electrochemically characterized the FeIII/II redox couple in various heme-thiolate 
enzymes.10-12  More recently, a putative FeII/I couple (~ -1100 mV vs. Ag/AgCl) was 
observed; in fact, the FeI species displayed catalytic activity towards reductive 
dehalogenation.13,14   
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The ability to electrochemically access FeIII/II and FeII/I redox couples in heme-
thiolate proteins within surfactant films led us to wonder if high-valent species could also 
be generated.  Conceivably, one- or two-electron oxidation of the FeIII–OH2 heme 
(resting state) should result in rapid conversion to the ferryl species FeIV=O–H  
(compound II) or FeV=O (compound I), as previously observed for horseradish 
peroxidase15 and chloroperoxidase.16  In the presence of substrates, these ferryl species 
may be capable of performing oxidative catalysis; note that this would occur in the 
absence of both dioxygen and NAD(P)H, both of which are necessary in the native 
system.   
Previous work has demonstrated that both oxidized and reduced Fe-porphyrin 
systems can be electrochemically accessed in non-aqueous media.17,18  Depending on the 
system, oxidation states from FeI to FeV can be generated, as well as porphyrin cations 
and anions.  For P450-type systems, it has been shown that FeIII-porphyrin complexes 
with basic axial ligands (cf. thiolate in P450) are oxidized first at the metal (FeIV), and 
then at the porphyrin macrocycle.19,20  Indeed, Groves and Gilbert have shown that in the 
presence of water, these hemes can be electrochemically oxidized to produce ferryl 
species capable of catalytic epoxidation.20   
 
Results and Discussion 
We performed cyclic voltammetry (CV) on cytochrome P450 CAM (CAM)* in 
didodecyldimethylammonium bromide (DDAB) films on the surface of basal plane 
graphite (BPG) electrodes and looked for evidence of protein and/or heme oxidation.  
                                                 
* The results reported for CAM are also observed in experiments with cytochrome P450 BM3.  However, 
voltammetry with CAM resulted in stronger current responses cf. BM3, making the data easier to interpret. 
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Preliminary CV experiments were conducted at 200 mV/s and pH 7 at room temperature 
by beginning at 0 mV, scanning negative to -700 mV, reversing the scan direction to 
1300 mV, and then cycling between 1300 mV and -700 mV.  In addition to observing the 
FeIII/II redox couple (E1/2 = -227 mV vs. Ag/AgCl), we also observed a large catalytic 
current corresponding to solvent oxidation at potentials > 900 mV.  After scanning 
beyond this solvent window, subsequent scanning in the region of the FeIII/II couple 
resulted in no observable signal, suggesting that the heme had been oxidatively damaged. 
 The above CV experiment was repeated at 50 V/s and pH 8 at room temperature.  
The resulting voltammogram (Figure 6.1) clearly reveals two couples: the FeIII/II redox 
couple centered at -227 mV, and a second couple (E) with E1/2 = 831 mV.  Accessing E 
was facilitated by scanning faster (> 30 V/s), and performing the experiment at higher pH 
(best at pH > 8).  E was found to be reversible above 30 V/s, and multiple CVs could be 
recorded without any significant loss in signal intensity.  Notably, it was possible to 
reversibly generate E at scan rates down to 1 V/s when performed at 4oC (Figure 6.2).  
There are three likely possibilities for the origin of E: 1) a porphyrin-centered redox 
process; 2) an amino acid redox process; 3) an Fe-centered redox process (i.e., FeIV/III).   
 ET reactions involving the macrocycle of an Fe-porphyrin are relatively 
insensitive to changes in the iron axial ligands or solution composition.21  In contrast, 
CVs recorded under different solution conditions indicated significant perturbations to E.  
First, voltammetry at constant ionic strength and variable pH (6-9) revealed that E varied 
with pH according to -(47 ± 7) mV/pH, indicating proton-coupled ET.†  Indeed, proton-
coupled ET is commonly observed for redox reactions in P450, consistent with a water-
ligated heme and the sensitivity of Fe-centered ET reactions to the aquo/hydroxo 
                                                 
† Notably, the FeIII/II couple varied similarly with pH according to –(41 ± 3) mV/pH. 
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equilibrium as the pH is increased.  Second, voltammetry in the presence of 500 mM 
imidazole (Figure 6.3) shows that E is inhibited.  This is in accord with a redox reaction 
involving a water-ligated FeIII heme: replacing the axial water with another ligand 
(imidazole in this case) would inhibit ferryl formation, as previously noted.22 
 To be rigorous, the possibility of an amino acid redox process for E must also be 
considered.  Likely amino acid candidates for E would be tyrosine (Eo’ = 0.74 V vs. 
Ag/AgCl) or tryptophan (Eo’ = 0.85 V) oxidation.23  Qualitatively, the peak intensities for 
E and the FeIII/II couple (Figure 6.1) are similar.  CAM contains nine tyrosine and five 
tryptophan residues. Thus, based on stoichiometry one would expect the signal intensity 
of E compared to FeIII/II to be several times greater if E were due to tyrosine or 
tryptophan; however, this is not the case.   
 These results lead us to envision the reaction pathway depicted in Scheme 6.1.  
Beginning with FeIII–OH2 (resting state), oxidation of this species would lead to FeIV=O–
H, which can decay in several ways.  First, rapid reduction would regenerate the resting 
state, FeIII–OH2.  Second, if reduction does not occur fast enough, oxidation of the 
surrounding protein environment by the ferryl species would likely result in damage to 
the protein.  This is supported by the observation that voltammetry at slower scan rates, 
or scanning at room temperature (cf. 4oC), results in loss of the FeIII/II couple.  Third, it is 
possible that if a ferryl species is indeed generated, it may be capable of oxidizing 
substrates and subsequently regenerating the FeIII–OH2 resting state. 
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 To test if the putative FeIV species was catalytically active, we performed 
electrolysis reactions with CAM-DDAB films on graphite electrodes at 0.9 V.‡  After 
trying several substrates (e.g., alkanes, styrene), we found that only thioanisole was 
oxidized by the system.  The results listed in Table 6.1 reveal that reactions with CAM 
produce significantly more methyl phenyl sulfoxide than control reactions without 
CAM.§,24  Additional controls with catalase present,** and films made with bovine serum 
albumin instead of CAM,†† further support a P450 FeIV-catalyzed oxidation reaction.   
The fact that only thioanisole is oxidized by FeIV-CAM suggests that the FeIV=O–
H in CAM (within the DDAB film) is not powerful enough to perform more challenging 
(alkene, alkane) oxidations.  The energetics associated with P450-type oxidations can be 
described in terms of bond dissociation energies (D(X–Y)).  D(O–H) of the 
electrochemically generated FeIV=O–H in CAM is related to the measured oxidation 
potential and the pKa of the FeIII–OH2 species,25,26 
D(O–H) (kcal/mol) = 23.06 x [Eo(FeIV/III)] + 1.37 x pKa(FeIII–OH2) + 57 
Previous work used this approach to demonstrate that D(O–H) at pH 6 for compound I in 
chloroperoxidase is 98 kcal/mol, making it potent enough to oxidize alkanes (D(C–H) ~ 
95 - 99 kcal/mol).  By contrast, oxidation of thioanisole at the sulfur followed by oxygen 
rebound (D(S–O) ~ 87 kcal/mol) is a more facile reaction.  Using the above equation, 
D(O–H) for FeIV=O–H in CAM in DDAB films at pH 6 is estimated to be 91 kcal/mol;‡‡ 
                                                 
‡ Electrolysis at more positive potentials resulted in loss of the protein response, and significantly decreased 
product formation.  There are several possibilities for this, including film desorption and oxidative protein 
damage. 
§ Direct oxidation of thioanisole to the sulfoxide (Eo = 1.3 V vs. Ag/AgCl) at the electrode can also occur. 
** Peroxide formed from water oxidation would also oxidize thioansiole. 
†† Films were made with BSA to rule out protein-mediated sequestering of the substrate into the film, 
followed by oxidation of the substrate directly at the electrode. 
‡‡ Eo at pH 6 is calculated to be 0.93 V vs. NHE; assumed FeIII–OH2 pKa = 9 
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this provides an explanation for the inability of the system to perform reactions more 
demanding than thioanisole oxidation.     
 
Experimental Methods 
Protein Expression and Purification 
Expression of CAM proceeded as previously described.27   
Buffers for protein purification were as follows: Buffer A – 50 mM KPi pH 7.2, 
500 µM camphor, 2 mM DTT; Buffer B – 50 mM KPi, 1 M KCl pH 7.2, 500 µM 
camphor, 2 mM DTT; Buffer C – 50 mM KPi, 30% saturated ammonium sulfate (176 
g/L) pH 7.2, 500 µM camphor, 2 mM DTT; Buffer D – 50 mM KPi, 50 mM KCl pH 7.4, 
2 mM DTT, 500 µM camphor.  All buffers were filtered and degassed using a vacuum 
filter. 
3 g of cell pellet cell were mixed with 9 mL of Buffer A containing 1 mM 
phenylmethylsulfonyl fluoride (PMSF, protease inhibitor).  Cells were lysed by 
sonication.  The lysate was centrifuged at 24,000 rpm for 30 min at 4oC.  The resulting 
supernatant was filtered using a 0.45 µm filter and then injected onto a 20 mL DEAE Fast 
Flow column equilibrated with Buffer A.  The protein was eluted with a linear gradient of 
0 – 500 mM KCl in Buffer A.  Fractions containing heme protein (visibly dark red) were 
pooled.  The protein from the pooled fractions was precipitated with 60% ammonium 
sulfate overnight at 4oC.  The mixture was then centrifuged at 12,500 rpm for 25 min at 
4oC.  The resulting pellet was resuspended in 2 - 5 mL of Buffer C.  The solution was 
loaded onto a phenyl sepharose column equilibrated with Buffer C.  Protein was eluted 
with a linear gradient of ammonium sulfate from 30 – 0 %.  Fractions with Abs395/Abs280 
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> 1 were collected, pooled, and concentrated to ~ 1 mL with a Millipore Centriprep 
concentrator.  The protein solution was injected onto a Sephacryl S200 column 
equilibrated with Buffer D.  The protein was eluted with a constant flow of Buffer D.   
Fractions with Abs395/Abs280 > 1.45 were pooled and concentrated using a Centriprep 
concentrator.   
Preparation of Protein Films for Voltammetry 
DDAB films were formed on BPG (0.07 cm2) by depositing 5 µL of a 10 mM 
aqueous solution of DDAB on the electrode surface, followed by slow drying overnight.  
CAM was incorporated into the film by soaking the coated electrode in a solution of 
enzyme (~ 10 µM in 30 mM KPi pH 7.4) for 30 minutes.   
Voltammetry was conducted in a three-comaprtment cell with an Ag/AgCl 
reference electrode (BAS) and Pt wire counter electrode.  The buffer was 50 mM KPi / 20 
mM KCl / pH 8.  Buffers for variable pH measurements were kept at constant ionic 
strength by adding different proportions of the monobasic and dibasic forms of potassium 
phosphate salts such that the final concentration was always 50 mM; the resulting pH was 
determined with a pH electrode.   
Voltammetry experiments at 4oC were performed in an ice-cooled water bath.   
Electrolysis and Thioanisole Oxidation 
 Electrodes for electrolysis were made from pyrolytic graphite plates, 1 cm x 2 cm, 
0.025 cm thick.  The plates were sanded, sonicated, and dried in air.  20 µL of a 10 mM 
solution of DDAB in ddH2O were applied and dried on each side of the graphite plate.  
Protein was incorporated into the films by soaking the filmed plates in a 5 µM CAM 
solution for 30 minutes.   
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 Electrolyses were performed in a three-neck flask at room temperature.  Working 
and counter (Pt gauze) electrodes were placed directly into solution, while the reference 
electrode was housed in a Luggin capillary.  Since preliminary experiments revealed that 
the presence of dioxygen in solution did not affect the electrolysis reaction, degassing the 
buffers was not necessary.  Reactions were performed in 6 mL of 50 mM KPi / 20 mM 
KCl / pH 8, with 100 µL thioanisole as substrate.  Reactions were conducted at 0.9 V 
with stirring for 10 minutes.  After the reaction, 5 uL of 1 mM 4-chloro-styrene were 
added (internal standard), followed by extraction of the solution with 0.5 mL CHCl3.  The 
CHCl3 layer was removed and analyzed by GC/MS using an Innowax column.  The 
product methyl phenyl sulfoxide was quantified relative to the internal standard using a 
calibration curve that was constructed by relating the ratio of the areas of the product to 
the internal standard.   
 Control reactions with BSA instead of CAM were conducted by soaking the 
filmed graphite plate in a solution that contained 6 µM BSA.  Control reactions with 
catalase were performed by adding 2 µL of a 47 mg/mL catalase stock solution to the 
reaction. 
 The amount of CAM incorporated into the films from solution was estimated by 
taking the absorption spectrum of the solution before and after soaking the filmed 
electrode.  The difference in Abs416 (ε416 = 115 mM-1cm-1) was used as the amount of 
CAM incorporated into the film.  Typically, 2 – 2.5 nmols of CAM were incorporated 
into the films on the PG plates. 
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Table 6.1.  Results from bioelectrocatalytic oxidation of thioanisole using CAM in 
DDAB on graphite.  Electrolyses were conducted at 0.9 V vs. Ag/AgCl for 10 minutes in 
6 mL 50 mM KPi / 20 mM KCl / pH 8 at ambient temperature.  
 
Reaction nmols methyl phenyl sulfoxide 
CAM in DDAB on PG 416 ± 14 
CAM in DDAB on PG + catalase 368 ± 20 
DDAB on PG 130 ± 14 
DDAB on PG + catalase 115 ± 20 
BSA in DDAB on PG 92 ± 14 
 
 
 
 
 
 
 
 
 
 
6-15 
 
 
 
 
Scheme 6.1. 
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Figure 6.1.  Cyclic voltammogram of CAM in DDAB on BPG (0.07 cm2) at 50 V/s in 50 
mM KPi / 50 mM KCl / pH 8, at ambient temperature.  
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Figure 6.2.  Cyclic voltammogram of CAM in DDAB on BPG (0.07 cm2) at 1 V/s in 50 
mM KPi / 50 mM KCl / pH 8, at 4oC.  
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Figure 6.3.  Cyclic voltammogram of CAM in DDAB on BPG (0.07 cm2) at 50 V/s in 50 
mM KPi / 50 mM KCl / pH 8, at ambient temperature in the presence of 500 mM 
imidazole.  
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Chapter 7 
 
Concluding Remarks 
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Abbreviations: BM3, cytochrome P450 BM3; ET, electron transfer;  
 
This thesis details a series of electrochemical systems for cytochrome P450 BM3 
(BM3).  The primary question originally identified in Chapter 1 is re-stated here: how 
can we efficiently deliver an electron from an external source, either from a soluble 
reductant or directly from an electrode, through the protein sheath and to the heme in a 
fashion that sufficiently mimics the native system in order to achieve catalytic substrate 
oxidation?  Several different systems were tried with varying degrees of success.  Over 
the course of developing the catalytic systems we discovered several intriguing 
mechanistic properties of P450, which we further explored and characterized 
electrochemically.  What follows is a summary of what we have learned from our 
investigations of the different systems. 
 
Summary 
The cobaltocene-mediated system for BM3 is an example of an electrochemical 
mediator designed for a given application (Chapter 2).  The new mediator was a 
significant finding, as only cobalt sepulchrate had previously been shown to be capable of 
supporting catalysis with BM3.1  Not only was cobaltocene able to mediate catalytic 
turnover, but we also demonstrated that the molecular scaffold was readily manipulated 
to suit our purposes (in this case, the added carboxyls raised the redox potential and 
rendered the mediator water-soluble).  Parallel studies with cobalt sepulchrate revealed 
that the two mediators are comparable in their ability to mediate BM3 bioelectrocatalysis.  
The primary drawback of cobaltocene, as with cobalt sepulchrate, is its reactivity towards 
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dioxygen: the active metal complex readily reduces dioxygen in solution, making 
peroxide and removing dioxygen (a co-substrate) from the reaction.   
Next, we attempted to replace the BM3 reductase domain by anchoring the heme 
domain to an electrode with a pyrene tether (Chapter 3).  Pyrene was attached to Cys387, 
which is part of a short peptide (amino acids 382-400) that is proposed to be involved in 
inter-domain electron transfer (ET).2  Indeed, the rapid heme reduction rates we achieved 
are fully consistent with the proposed ET pathway.  In fact, heme reduction was so rapid 
that electrolysis conducted aerobically resulted in four-electron transfer to dioxygen, 
forming primarily water.  Unfortunately, catalytic substrate oxidation was not observed.  
Several factors likely contribute to this: 1) protein aggregation on the electrode surface, 
as revealed by AFM; 2) an altered heme environment, as suggested by voltammetry in 
CO-saturated buffer; 3) unregulated ET that leads to direct dioxygen reduction instead of 
formation of active iron-oxo intermediates. 
Extensive electrochemical characterization of BM3 was made by confining the 
protein within surfactant films on electrode surfaces (Chapters 4 and 5).  DDAPSS films 
proved to be the most effective based on the stability of the voltammetric response.  
Catalytic activities included dioxygen reduction by FeII and reductive dechlorination by 
FeI; notably, this is the first reported instance of FeI in BM3.  Perhaps most significant 
was our finding that wild type BM3 and mutant 1-12G display distinct redox properties.  
The BM3 literature contains many mutagenesis studies that alter the enzyme’s substrate 
and product profiles, with little insight into how these mutations affect the biochemistry 
and redox chemistry.  Our study demonstrates that wild type and 1-12G possess distinct 
heme environments within the DDAPSS film: the results support a mechanism for 1-12G 
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that features a longer lived iron-peroxy complex, which can justify 1-12G’s superior 
ability to regio- and stereoselectively hydroxylate linear alkanes.   
While useful for mechanistic studies, the surfactant film systems were not capable 
of supporting substrate oxidation.  Several studies have shown that heme proteins within 
surfactant films retain their solution spectroscopic properties,3,4 suggesting that they 
should be able to perform native enzyme chemistry.  However, we have found that our 
P450-surfactant film electrodes are only competent for simple reduction reactions.  One 
possibility for the lack of oxidative activity is that the substrates were not accessible by 
the protein.  It is conceivable that the substrates preferentially partition into the film, or 
cannot enter the active site because the protein is in a closed conformation within the 
film.  However, the ability of our systems to perform catalytic dechlorination of 
trichloroacetic acid argues against this point.  A second and perhaps more likely 
possibility is that our systems are not able to reach active iron-oxo intermediates, as 
direct reduction to peroxide or water is very rapid. 
In Chapter 6, we utilized the surfactant film methodology to electrochemically 
access a high-potential redox couple (E) in P450.  Electrochemical characterization 
suggests that E represents the first observation of a high-valent species in P450, formally 
a one-electron oxidation of the FeIII resting state.  Our data indicate the oxidation reaction 
is occurring at the metal center, suggesting an FeIV/III couple.  E was found capable of 
catalyzing thioansiole oxidation.  The inability of E to perform reactions other than S-
oxidation suggests that it is not potent enough (within the surfactant film) to catalyze 
more challenging oxidations.  This is not surprising since compound I, the putative 
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oxidizing species in P450, is two oxidation states higher than FeIII heme, while E is only 
one oxidation state higher. 
 
Perspectives 
  While electrochemistry in surfactant films does not appear to be viable for bulk 
oxidation reactions, it has proven to be an invaluable analytical tool.  Our work on these 
systems has shed considerable light on the mechanisms in heme-thiolate proteins (wild 
type and mutant BM3 in Chapter 5, cytochrome P450 CAM in Chapter 6, nitric oxide 
synthase in Appendix A).  Future endeavors into P450-surfactant film voltammetry 
should be aimed at spectroelectrochemical experiments, using transparent electrodes to 
observe the spectral properties of the different heme oxidation states.  In particular, it is 
imperative to provide spectroscopic evidence to confirm the FeII/I and FeIV/III redox 
couples.  This can be done with absorption spectroscopy by looking at changes in the 
heme Soret band during redox cycling, and comparing the results to iron-porphyrin 
model complexes with known spectra.5,6 
Only the mediator system was capable of catalytic substrate (C–H) oxidation, 
while utilizing the holo protein yielded results far superior to the heme domain.  These 
findings are not surprising.  Using a soluble mediator with the holo protein most closely 
resembles the native system, which immediately alludes to two key points.  First, 
allowing the protein to remain in solution permits retention of its native fold and 
dynamics, which are likely key determinants for catalytic activity.  Indeed, this is an 
inherent failing of the systems that confined the protein to the electrode surface, which 
may restrict necessary conformational changes for catalysis.7   
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Second, the role of the reductase domain in regulating ET to the heme cannot be 
underestimated.  The pyrene system most clearly demonstrates this point: although we 
appeared to successfully replace the reductase with an electrode for ET to the heme, the 
loss of regulation provided by the reductase resulted in heme reduction that was too 
rapid.  As a result, instead of activating dioxygen for subsequent oxygen atom transfer, 
we achieved rapid four-electron reduction of dioxygen to water.   
Of the various challenges associated with using P450s as in vitro catalysts, the 
requirement for reducing equivalents remains the greatest obstacle.  Utilizing an electrode 
is still the simplest and most cost-effective way of replacing NADPH in the catalytic 
cycle of BM3.  The results presented herein indicate that the most promising system for 
large-scale biocatalysis would be to utilize a small molecule electrochemical mediator 
with the holo protein.  The key is to find a mediator that: 1) is capable of participating in 
rapid and reversible ET with both the electrode and enzyme; 2) can be electrochemically 
reduced at moderate potentials, such that the electrode does not need to be polarized too 
negatively (which would result in solvent reduction, and possibly other side reactions); 3) 
does not readily reduce dioxygen in solution; 4) is easily manipulated synthetically, 
permitting versatility (adapt it to different solution conditions, provide a range of redox 
potentials, etc.).  These criteria are in accord with those previously presented for 
bioelectrochemical mediators.8 
Future endeavors into this problem should focus on mediators that participate in 
hydride transfer, such as quinones and certain organometallic complexes.  Analogous to 
cobaltocene, these molecules would have the advantage of synthetic malleability, while 
displaying significantly decreased reactivity towards dioxygen.  Indeed, a hydride 
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transfer mediator would more closely mimic the native system since NADPH also 
functions in this manner.  Some success with a hydride transfer mediator has already 
been demonstrated by Witholt’s group: they utilized a rhodium complex that was capable 
of regenerating the flavin cofactors of styrene monooxygenase, resulting in catalytic 
substrate turnover.9  Mediator turnover was also shown to be highly coupled to substrate 
turnover (60%, cf. 2% for cobaltocene), with few electrons wasted on direct reduction of 
dioxygen in solution.  Conceivably, a similar mediator for BM3 would result in a system 
that could function aerobically at acceptable rates for in vitro electrode-driven catalytic 
substrate oxidation. 
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Abstract 
We report direct electrochemistry of the iNOS heme domain in a DDAB film on 
the surface of a basal plane graphite electrode.  Cyclic voltammetry reveals FeIII/II and 
FeII/I couples at -191 and -1049 mV (vs. Ag/AgCl).  Added ligands imidazole and carbon 
monoxide shift the FeIII/II potential by +20 and +62 mV, while the addition of dioxygen 
results in large catalytic waves at the onset of FeIII reduction.  Voltammetry at higher scan 
rates reveals that the FeIII/II cathodic peak can be resolved into two components, which are 
attributable to FeIII/II couples of five- and six-coordinate hemes.  Scan rate analyses of the 
five-coordinate iNOS heme indicate an ET rate constant (ko) of 370 ± 20 s-1.   
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Abbreviations: NO, nitric oxide; NOS, nitric oxide synthase; ET, electron transfer; H4B, 
tetrahydrobiopterin; iNOS, inducible nitric oxide synthase; DDAB, 
didodecyldimethylammonium bromide; BPG, basal plane graphite; nNOS, neuronal nitric 
oxide synthase 
 
Introduction 
The critical role of nitric oxide (NO) in cellular signaling is now firmly 
established.1  In higher animals, NO is synthesized by nitric oxide synthase (NOS), which 
converts L-arginine to citrulline and NO with NADPH and O2 as co-substrates.2  The 
enzyme consists of a reductase domain where reducing equivalents from NADPH are 
shuttled through bound flavins FAD and FMN, a calmodulin binding region that controls 
electron transfer (ET) to the heme, and a heme domain that contains a cysteine-ligated 
heme and tetrahydrobiopterin (H4B).  Investigations reported here utilize the heme 
domain of inducible NOS (iNOS), an immune system isoform implicated in a number of 
diseases in humans.3 
The complexity of NOS and its impact on human health have thrust work on the 
NOS mechanism into the spotlight.  It is well established that the catalytic cycle involves 
two turnovers of the enzyme.  The first turnover converts L-arginine to N-
hydroxyarginine: although envisioned as a P450-like hydroxylation, the reaction is 
dependent on one-electron oxidation of H4B.4  The second turnover is thought to involve 
a ferric peroxide nucleophile, but H4B is also required for this turnover in an as yet 
undetermined role.  Although many details of the NOS mechanism remain to be 
elucidated, it is certain that ET reactions are key steps in the catalytic cycle.   
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Direct electrochemistry of the iNOS heme domain can be achieved by confining 
the protein in didodecyldimethylammonium bromide (DDAB) films on the surface of 
basal plane graphite electrodes (BPG).5,6  We report reduction potentials for FeIII/II and 
FeII/I couples, FeIII/II ET kinetics, catalytic reduction of dioxygen, and evidence for water-
free and water-bound forms of the iNOS heme based on scan rate and pH dependence 
data. 
 
Results and Discussion 
DDAB films were formed on BPG (0.07 cm2) by depositing 5 µL of a 10 mM 
aqueous solution of DDAB on the electrode surface, followed by slow drying overnight.  
iNOS was incorporated into the film by soaking the coated electrode in a solution of 
enzyme (~ 20 µM in 50 mM KPi, 50 mM KCl, pH 7 buffer) for 30 minutes.  A 
voltammogram of iNOS in DDAB on BPG is shown in Figure A.1.  We have assigned 
E1 (-191 mV) and E2 (-1049 mV) to heme FeIII/II and FeII/I couples, consistent with other 
studies of heme proteins in DDAB films.7,8  Notably, a couple similar to E2 was observed 
for neuronal nitric oxide synthase (nNOS), but was not assigned.5  Our assignments of E1 
and E2 are supported by voltammetry in the presence of carbon monoxide: E1 shifts 
approximately +62 mV (consistent with other studies),9,10 while E2 is not observed 
(presumably beyond the solvent window).  For comparison, redox titrations of iNOS in 
its resting state (6-coordinate heme, low spin) conducted in solution yield a potential of  
-544 mV (vs. Ag/AgCl) for FeIII/II.11  As previously suggested, local electrostatic effects 
likely contribute to the altered potential on the electrode surface.12 
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Besides CO, other molecules in solution also bind the heme.  In the presence of 
500 mM imidazole, E1 shifts +20 mV.  When dioxygen is added, large catalytic reduction 
currents at the onset of E1 are observed (Figure A.2). 
For E1, the peak current is linear with scan rate (surface-bound) up to 16.7 V/s, 
after which it is linear with the square root of the scan rate (diffusive).13  This behavior is 
characteristic of thin film electrochemistry and indicates finite diffusion of the protein 
within the film.14  Thus, up to 16.7 V/s, we treated the redox system as surface-confined.   
Closer inspection of Figure A.1 reveals that the E1 cathodic wave is slightly 
broader than the other waves.  Voltammetry at variable scan rates allowed us to resolve 
this peak into two distinct cathodic processes, Ep,c(1) and Ep,c(2).  Figure A.3a shows 
voltammograms recorded in pH 7 buffer at different scan rates.  At high and low scan 
rates (8 vs. 0.05 V/s) only one cathodic peak (Ep,c(1) vs. Ep,c(2)) is present, while both 
cathodic processes are observed at intermediate (1 V/s) scan rates.  In addition to being 
scan rate dependent, these cathodic processes are also pH dependent.  At pH 5 and 1 V/s 
(Figure A.3b), only one cathodic peak (Ep,c(1)) is present.  Conversely, at pH 9 two 
distinct cathodic peaks are visible at 1 V/s (Figure A.3c); in fact, at higher pH, Ep,c(2) is 
even more prominent.  Notably, during the first cathodic sweep Ep,c(2) predominates, 
while in subsequent cathodic sweeps both Ep,c(1) and Ep,c(2) are resolved.   
This pH and scan rate dependence led us to believe that the iNOS heme axial 
water ligand is involved in an equilibrium that gives rise to Ep,c(1) and Ep,c(2) (Scheme 
A.1).  At pH 7 and 1 V/s, the first cathodic sweep results in Ep,c(2): this correlates with 
initial reduction of FeIII – OH2.  The lability of the FeII – OH2 bond results in rapid 
conversion to a five-coordinate heme.15,16  Oxidation of FeII to FeIII, followed by a second 
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cathodic sweep at intermediate scan rates (1 V/s, Figure A.3a) gives rise to two reduction 
peaks, corresponding to reduction of water-free (Ep,c(1)) and water-bound (Ep,c(2)) FeIII 
hemes. 
Our interpretation is supported by the following observations.  First, Ep,c(1) and 
Ep,c(2) differ by approximately 133 ± 9 mV, a value consistent with the potential 
difference between five- and six-coordinate iNOS hemes.11  Second, voltammetry at low 
pH results in a single cathodic peak attributable to Ep,c(1).  Under acidic conditions, 
disruption of hydrogen bonding in the heme pocket likely leads to dissociation of the 
axial water, resulting in a five-coordinate heme.  Third, voltammetry at high pH (Figure 
A.3c), where the axial water is partially deprotonated, shows that Ep,c(2) is more 
prominent.  It is expected that hydroxide will have greater affinity for the cationic metal 
center, thereby shifting the cathodic peak distribution further to Ep,c(2).  Fourth, 
voltammetry with imidazole present yields a single cathodic process, consistent with 
constant heme ligation as it cycles between oxidation states (Figure A.4).17   
The dependence of the cathodic peak distribution on scan rate can be explained in 
terms of Scheme A.1.  At high scan rates, after oxidation of FeII, reduction of water-free 
FeIII occurs faster than water ligation to FeIII, yielding only Ep,c(1).  Conversely, scanning 
slowly allows water enough time to ligate FeIII before reduction, shifting the cathodic 
peak distribution to Ep,c(2).  Thus, intermediate scan rates yield both Ep,c(1) and Ep,c(2). 
Using Ep,c(1), ko (∆Go = 0) for ET to the five-coordinate heme evaluated at 16.7 
V/s and pH 7 is 370 ± 20 s-1.18  With this value, we used digital simulation to effectively 
model the experimental results in Figure A.3a (see Experimental Methods).  From the 
simulation, we estimated values for k1, k2, and k3 in Scheme A.1 to be 1 s-1, 0.5 s-1, and > 
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100 s-1.  As expected,15,16 water dissociation from FeII is rapid (k3), while the kinetics of 
the FeIII equilibrium with water (k1, k2) appear slow.  In the catalytic cycle of iNOS, the 
first ET event is proposed to be the rate-limiting step for substrate turnover, occurring at 
1 s-1.19  Based on our simulation, we suggest that water dissociation from FeIII may 
function as a potential gating mechanism for the catalytic cycle.  Although speculative for 
iNOS, water-gated ET is consistent with what is known for the similar cytochromes 
P450. 
Proton-coupled ET was observed for nNOS in DDAB films as demonstrated by 
the variation of E1/2 with pH.5  For comparison, we performed voltammetry on iNOS at 
200 mV/s and plotted the variation of E1/2 with pH for E1 (Figure A.3d).20  The data 
reveal no variation of E1/2 for pH < 5, implying simple conversion of five-coordinate FeIII 
to FeII.  At pH > 7, E1/2 varies linearly with pH according to -53 mV/pH unit, as is often 
found for heme proteins.21,22  The observation of proton-coupled ET in a pH range where 
the heme is water-ligated further underscores that the heme axial water ligand plays a 
significant role in iNOS ET.   
 
Experimental Methods 
Protein Expression and Purification 
 iNOS heme domain was expressed and purified as previously described23 with the 
following exceptions.  Cells expressing protein were subjected to two rounds of chemical 
lysis.  Cell pellets were resuspended in 40 mL of B-PER lysis buffer (Pierce) with 10 
µg/mL benzamidine, 5 µg/mL leupeptin, 1 µg/mL each pepstatin, antipain, and 
chymotrypsin, ~ 500 µM Pefabloc (Roche), 100 µg/mL DNAse, 100 µg/mL RNAse, ~ 
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500 µg/mL lysozyme, and 20 mM imidazole per liter of cells and shaken for one hour at 
4oC.  The lysate was then spun down and the supernatant was loaded directly onto a 
nickel column (5 mL HisTrap, Amersham).  The loaded column was washed with 20 
column volumes of 20 mM imidazole in 50 mM NaPi/300 mM NaCl/pH 8.  The protein 
was eluted with 150 mM imidazole, concentrated to ~ 3 mL over an Amicon Ultra 
filtration device (10,000 MWCO, Millipore) and loaded onto a gel filtration column as 
previously described.23  The anion exchange column was omitted when ≥ 95% purity was 
confirmed by UV-visible spectroscopy and gel electrophoresis. 
Electrode Preparation and Voltammetry 
Electrodes for voltammetry (0.07 cm2) were made using the basal plane of 
pyrolytic graphite.  The surfaces were prepared by sanding briefly with 600-grit 
sandpaper, followed by polishing with 0.3 and 0.05 µm alumina slurries.  The electrodes 
were then sonicated and dried in air.  DDAB films were formed by placing 5 µL of 10 
mM DDAB in water on the surface of the electrodes, followed by slow drying in air 
overnight.  iNOS was incorporated into the film by soaking the DDAB-filmed electrode 
in a solution of enzyme (~ 20 µM in 50 mM KPi pH 7 buffer) for 30 minutes, followed 
by gentle rinsing with ddH2O.   
 A CH Instruments Electrochemical Workstation system was used for the 
reactions.  Voltammetry experiments were performed in a three-compartment cell, using 
a platinum wire auxiliary and a Ag/AgCl reference electrode (BAS).  All experiments 
were performed under argon in thoroughly degassed buffer (50 mM KPi, 50 mM KCl, pH 
7) unless otherwise stated. 
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Digital Simulations 
 Simulations were performed with software from the CH Instruments 
Electrochemical Workstation.  A square scheme was used for the model: 
 
ko for the five-coordinate heme ET reaction was experimentally determined to be 370 s-1.  
For the six-coordinate heme ET reaction, a ko value of 10 s-1 (consistent with previous 
observations for NOSs24) resulted in the best simulated voltammograms. A surface-
confined system was modeled with the following parameters: capacitance = 4 µF, surface 
coverage = 5 x 10-11 mol/cm2, electrode area = 0.07 cm2, Eo(FeIII/II) = -150 mV, Eo(FeIII/II 
– OH2) = -250 mV.  Values for k1, k2, and k3 were entered into the simulation until a 
single set of rate constants was found that could adequately reproduce the experimentally 
derived voltammograms at 0.05, 1, and 8 V/s at pH 7 (Figure A.3a).  For each 
simulation, k4 was determined by the software.  Using this procedure, values for k1, k2, 
and k3 of 1 s-1, 0.5 s-1, and 100 s-1, respectively, were able to accurately model the 
voltammograms in Figure A.3a (see Figure A.5).  Notably, the simulation was 
insensitive for values of k3 > 100 s-1.   
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Figure A.1.  Cyclic voltammogram of iNOS in DDAB on BPG (0.07 cm2) at 200 mV/s 
in 50 mM KPi/50 mM KCl/pH7.   
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Figure A.2.  Cyclic voltammogram of iNOS in DDAB on BPG at 200 mV/s in 50 mM 
KPi/50 mM KCl/pH 7 and 94 µM O2.   
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Figure A.3.  Cyclic voltammograms of iNOS in DDAB on BPG in 50 mM KPi/50 mM 
KCl a) at 0.05 (black), 1 (gray), and 8 (dashed) V/s, pH 7; b) at 1 V/s, pH 5; c) at 1 V/s, 
pH 9.  d) Variation of the average FeIII/II midpoint potential with pH at 200 mV/s.   
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Figure A.4.  Cyclic voltammogram of iNOS in DDAB on BPG in 50 mM KPi/50 mM 
KCl/pH 7 and 500 mM imidazole at 1 V/s.  Note that only a single cathodic process is 
observed (cf. Figure A.3a). 
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Figure A.5.  Digitally simulated voltammograms at a) 0.05 (black), b) 1 (gray), and c) 8 
(dashed) V/s for iNOS in DDAB films.  Simulation details are listed in the Experimental 
Methods. 
 
 
